USRE31006E
(en)
*
|
1968-09-24 |
1982-08-03 |
Akzona Incorporated |
Process for the demonstration and determination of reaction components having specific binding affinity for each other
|
NL171930C
(nl)
*
|
1972-05-11 |
1983-06-01 |
Akzo Nv |
Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
|
US3790447A
(en)
*
|
1972-07-05 |
1974-02-05 |
Abbott Lab |
Streptococci diagnostic method
|
DE2333434C3
(de)
*
|
1973-06-30 |
1978-04-06 |
Istvan D. Dr. 5024 Pulheim Bartos |
Verfahren zur Durchführung serologischer Untersuchungen nach dem Prinzip der Komplementbindungsreaktion und gebrauchsfertige Schnelltestpackung hierfür
|
US4239746A
(en)
*
|
1973-06-30 |
1980-12-16 |
Dezso Istvan Bartos |
Complement fixation test employing reactants in a disposable package
|
US3935074A
(en)
*
|
1973-12-17 |
1976-01-27 |
Syva Company |
Antibody steric hindrance immunoassay with two antibodies
|
GB1508132A
(en)
*
|
1974-05-20 |
1978-04-19 |
Technicon Instr |
Analysis of biological fluids
|
US4040907A
(en)
*
|
1974-06-20 |
1977-08-09 |
Syva Company |
Iodothyronine enzyme conjugates
|
US4001087A
(en)
*
|
1974-10-10 |
1977-01-04 |
The United States Of America |
Affinity labelling enzymes with esters of aromatic sulfonic acids
|
FR2288312A1
(fr)
*
|
1974-10-14 |
1976-05-14 |
Pasteur Institut |
Procede de dosage immunoenzymatique de la progesterone
|
US4002532A
(en)
*
|
1974-10-21 |
1977-01-11 |
Weltman Joel K |
Enzyme conjugates
|
SE388694B
(sv)
*
|
1975-01-27 |
1976-10-11 |
Kabi Ab |
Sett att pavisa ett antigen exv i prov av kroppvetskor, med utnyttjande av till porost berarmaterial bundna eller adsorberande antikroppar
|
NL7501215A
(nl)
*
|
1975-02-01 |
1976-08-03 |
Akzo Nv |
Methode voor het aantonen en bepalen van een antigeen of antilichaam.
|
US4629688A
(en)
*
|
1975-04-28 |
1986-12-16 |
Miles Laboratories, Inc. |
Homogeneous specific binding assay method
|
US4230797A
(en)
*
|
1975-04-28 |
1980-10-28 |
Miles Laboratories, Inc. |
Heterogenous specific binding assay employing a coenzyme as label
|
USRE32696E
(en)
*
|
1975-09-04 |
1988-06-14 |
Akzona Incorporated |
Enzymatic immunological method for determination of antigens and antibodies
|
US4642285A
(en)
*
|
1975-09-29 |
1987-02-10 |
Diamedix Corporation |
Sandwich EIA for antigen
|
SE7610683L
(sv)
*
|
1975-09-29 |
1977-06-10 |
Cordis Corp |
Metod for bestemning av nervaron av ett antigen associerat med hepatit
|
US4474878A
(en)
*
|
1975-09-29 |
1984-10-02 |
Cordis Laboratories, Inc. |
Sandwich EIA for antigen associated with hepatitis
|
JPS5272284A
(en)
*
|
1975-12-12 |
1977-06-16 |
Dainippon Pharmaceutical Co |
Enzymeeimmunoassay reagent
|
US4045384A
(en)
*
|
1976-07-23 |
1977-08-30 |
The Dow Chemical Company |
Method for forming an amide bond between a latex and protein
|
GB1549069A
(en)
*
|
1976-12-10 |
1979-08-01 |
Erba Farmitalia |
Enzyme linked immunoassay
|
US4407943A
(en)
*
|
1976-12-16 |
1983-10-04 |
Millipore Corporation |
Immobilized antibody or antigen for immunoassay
|
US4200690A
(en)
*
|
1976-12-16 |
1980-04-29 |
Millipore Corporation |
Immunoassay with membrane immobilized antibody
|
JPS5399319A
(en)
*
|
1977-02-09 |
1978-08-30 |
Hidematsu Hirai |
Novel qualitative and quantitative detecting method and detecting body for antgenic substance
|
IT1114861B
(it)
*
|
1977-05-12 |
1986-01-27 |
Sclavo Inst Sieroterapeut |
Metodo per la determinazione del contenuto di costituenti di fluidi biologici e mezzi adatti allo scopo
|
AU531777B2
(en)
*
|
1978-04-05 |
1983-09-08 |
Syva Co. |
Label/solid conjugate immunoassay system
|
US4233402A
(en)
*
|
1978-04-05 |
1980-11-11 |
Syva Company |
Reagents and method employing channeling
|
US4318980A
(en)
*
|
1978-04-10 |
1982-03-09 |
Miles Laboratories, Inc. |
Heterogenous specific binding assay employing a cycling reactant as label
|
US4492751A
(en)
*
|
1978-04-10 |
1985-01-08 |
Miles Laboratories, Inc. |
Heterogenous specific binding assay employing an enzyme substrate as label
|
FR2422956A1
(fr)
*
|
1978-04-13 |
1979-11-09 |
Pasteur Institut |
Procede de detection et de caracterisation d'un acide nucleique ou d'une sequence de celui-ci, et reactif enzymatique pour la mise en oeuvre de ce procede
|
US5605800A
(en)
*
|
1978-04-13 |
1997-02-25 |
Institut Pasteur |
Method of detecting and characterizing a nucleic acid or a sequence of the latter, and enzymatic reactant for the application of this method
|
JPS5510590A
(en)
*
|
1978-05-04 |
1980-01-25 |
Wellcome Found |
Enzyme immunity quantity analysis
|
JPS5539702A
(en)
*
|
1978-08-30 |
1980-03-19 |
Takeda Chem Ind Ltd |
Method of measuring enzyme immunity of pancreas glucagon
|
FR2440555A1
(fr)
*
|
1978-10-31 |
1980-05-30 |
Maes Roland |
Perfectionnements aux procedes de determination de substances montrant entre elles des affinites de liaison specifiques, par des tests faisant intervenir une phase solide
|
US4260678A
(en)
*
|
1979-02-23 |
1981-04-07 |
Corning Glass Works |
Determining creatine kinase isoenzmes via immobilized antibody-isoenzyme complexes
|
JPS55152459A
(en)
*
|
1979-05-18 |
1980-11-27 |
Yamasa Shoyu Co Ltd |
Method and reagent for measuring quantity of cyclic nucleotide
|
US4289748A
(en)
*
|
1979-05-31 |
1981-09-15 |
United States Of America |
Ultrasensitive enzymatic radioimmunoassay method
|
DE2930706A1
(de)
*
|
1979-07-28 |
1981-02-05 |
Medac Klinische Spezialpraep |
Verfahren zum nachweis von erregerspezifischen antikoerpern
|
US4299916A
(en)
*
|
1979-12-26 |
1981-11-10 |
Syva Company |
Preferential signal production on a surface in immunoassays
|
US4394391A
(en)
*
|
1980-02-19 |
1983-07-19 |
Thorell Jan Ivan |
Radioimmunoassay reagents
|
US4322495A
(en)
*
|
1980-03-11 |
1982-03-30 |
Minnesota Mining And Manufacturing Co. |
Immunoassay
|
SE8003732L
(sv)
*
|
1980-05-19 |
1981-11-20 |
Pharmacia Diagnostics Ab |
Sett vid bestemningsmetoder involverande biospecifika affinitetsreaktioner
|
EP0040728A1
(de)
*
|
1980-05-19 |
1981-12-02 |
Pharmacia Diagnostics Ab |
Prüfverfahren, welche biospezifische Affinitätsreaktionen umfassen
|
JPS5714748A
(en)
*
|
1980-07-01 |
1982-01-26 |
Dainippon Pharmaceut Co Ltd |
Kit for quantitative determination of valproic acid and its method for quantitative determination
|
US4323647A
(en)
*
|
1980-10-15 |
1982-04-06 |
University Of Miami |
Steric hindrance enzyme immunoassay
|
DE3048884A1
(de)
*
|
1980-12-23 |
1982-07-15 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Verfahren zur enzymimmunobestimmung in heterogener phase
|
ES511156A0
(es)
*
|
1981-04-13 |
1983-08-01 |
Hoechst Co American |
Un metodo de determinar la presencia de un antigeno en un medio liquido sospechoso de contenerlo.
|
US4604365A
(en)
*
|
1981-06-02 |
1986-08-05 |
Electro-Nucleonics, Inc. |
Immunoprecipitation assay
|
DE3265823D1
(en)
*
|
1981-06-02 |
1985-10-03 |
Electro Nucleonics |
Immunoprecipitation assay
|
US4506009A
(en)
*
|
1982-03-30 |
1985-03-19 |
University Of California |
Heterogeneous immunoassay method
|
US4535057A
(en)
*
|
1982-07-26 |
1985-08-13 |
Amf Incorporated |
Immunoassay employing monoclonal herpes simplex antibody and biotin-avidin detection system
|
US4515890A
(en)
*
|
1982-11-08 |
1985-05-07 |
Abbott Laboratories |
Immunoassay of terminal deoxynucleotidyl transferase
|
US4650751A
(en)
*
|
1983-04-29 |
1987-03-17 |
Technicon Instruments Corporation |
Protected binding assay avoiding non-specific protein interference
|
US4778752A
(en)
*
|
1983-10-11 |
1988-10-18 |
Scripps Clinic And Research Foundation |
Receptors specific for hapten-modified self proteins
|
EP0229767B1
(de)
*
|
1985-03-18 |
1990-09-26 |
Royal Free Hospital School Of Medicine |
Verbesserungen in bezug auf nachweis von viren und antikörpern
|
JPS62148857A
(ja)
*
|
1985-12-24 |
1987-07-02 |
Toyo Soda Mfg Co Ltd |
免疫測定用材料の製造方法
|
EP0247730A3
(de)
*
|
1986-04-28 |
1989-04-12 |
Antibody Technology Limited |
Antikörper, ihre Herstellung sowie Verwendung und dieselben enthaltende Produkte
|
DE3636724A1
(de)
*
|
1986-10-29 |
1988-06-23 |
Joern Dr Med Kekow |
Enzymimmunoassay (elisa) zur insulinbestimmung im mikrotiterplattensystem
|
US6528292B1
(en)
*
|
1987-05-29 |
2003-03-04 |
Aventis Pharmaceuticals Holdings Inc. |
Derivatized polystyrene and other polymer supports for spectroscopic studies
|
US5256372A
(en)
*
|
1987-11-06 |
1993-10-26 |
Idexx Corporation |
Dipstick test device including a removable filter assembly
|
US5374524A
(en)
*
|
1988-05-10 |
1994-12-20 |
E. I. Du Pont De Nemours And Company |
Solution sandwich hybridization, capture and detection of amplified nucleic acids
|
US5137804A
(en)
*
|
1988-05-10 |
1992-08-11 |
E. I. Du Pont De Nemours And Company |
Assay device and immunoassay
|
US5614504A
(en)
*
|
1990-08-01 |
1997-03-25 |
The University Of South Florida |
Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
|
US5965379A
(en)
*
|
1991-07-19 |
1999-10-12 |
Cytimmune Sciences Inc. |
Method for measuring endogenous cytokines
|
JP3183666B2
(ja)
*
|
1991-07-19 |
2001-07-09 |
アツセイ・リサーチ・インコーポレーテツド |
内因性サイトカイン類の測定方法およびキット
|
US5464749A
(en)
|
1991-07-22 |
1995-11-07 |
Bayer Corporation |
Immunoassay of free substances in biological fluids
|
US5874423A
(en)
*
|
1992-09-10 |
1999-02-23 |
Yissum Research Development Co. Of The Hebrew University Of Jerusalem |
Digitalis-like compounds
|
US5637467A
(en)
*
|
1992-10-13 |
1997-06-10 |
Behringwerke Ag |
Heterogeneous assay using a pendulous drop
|
WO1995034640A1
(en)
*
|
1994-06-13 |
1995-12-21 |
Henry Ford Health System |
A novel neuronal-neonatal gene: neuronatin
|
US6531277B2
(en)
|
1994-10-25 |
2003-03-11 |
The Curators Of The University Of Missouri |
Endometriosis-specific secretory protein
|
US5843673A
(en)
*
|
1994-10-25 |
1998-12-01 |
Curators Of The University Of Missouri |
Method of screening for endometriosis
|
US20030152909A1
(en)
*
|
1994-11-16 |
2003-08-14 |
Mitrani Eduardo N. |
In vitro micro-organs, and uses related thereto
|
US5607565A
(en)
*
|
1995-03-27 |
1997-03-04 |
Coulter Corporation |
Apparatus for measuring analytes in a fluid sample
|
US5728807A
(en)
*
|
1995-05-16 |
1998-03-17 |
Ramot-University Authority For Applied Research And Industrial Development, Ltd. |
Mutated proteins associated with ataxia-telangiectasia
|
US5777093A
(en)
*
|
1995-05-16 |
1998-07-07 |
Ramot-University Authority For Applied Research & Industrial Development Ltd. |
cDNAs associated with ataxia-telangiectasia
|
US5858661A
(en)
|
1995-05-16 |
1999-01-12 |
Ramot-University Authority For Applied Research And Industrial Development |
Ataxia-telangiectasia gene and its genomic organization
|
US6096508A
(en)
*
|
1995-08-16 |
2000-08-01 |
Kirkegaard & Perry Laboratoies, Inc. |
Method of reducing background in biotin-based assays
|
US5840322A
(en)
*
|
1996-12-19 |
1998-11-24 |
Ramot-University Authority For Applied Research & Industrial Devel. Ltd. |
Anti-oral-microbial adhesion fraction derived from vaccinium
|
US7973156B2
(en)
|
1997-08-21 |
2011-07-05 |
Quark Pharmaceuticals Inc. |
Hypoxia-regulated genes
|
AU9110798A
(en)
|
1997-08-21 |
1999-03-08 |
Quark Biotech, Inc. |
Hypoxia-regulated genes
|
US6284496B1
(en)
|
1997-10-03 |
2001-09-04 |
University Of South Florida |
DNA vector for determining the presence of out-of-reading-frame mutations
|
AU748467B2
(en)
|
1997-10-17 |
2002-06-06 |
University Of South Florida |
Method to diagnose and monitor cellular immune deficiencies
|
US7687057B2
(en)
|
1998-01-09 |
2010-03-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
In vitro micro-organs, and uses related thereto
|
US20080206206A1
(en)
|
1998-05-07 |
2008-08-28 |
University Of South Florida |
Bone marrow-derived neuronal cells
|
US6344443B1
(en)
|
1998-07-08 |
2002-02-05 |
University Of South Florida |
Peptide antagonists of tumor necrosis factor alpha
|
AU4994899A
(en)
|
1998-07-13 |
2000-02-01 |
University Of South Florida |
Modulation of the phospholipase a2 pathway as a therapeutic
|
US6187563B1
(en)
|
1998-08-07 |
2001-02-13 |
Yale University |
βIV-spectrin-polypeptides and nucleic acids encoding same
|
IL142094A0
(en)
|
1998-09-29 |
2002-03-10 |
Gamida Cell Ltd |
Methods of controlling proliferation and differentiation of stem and progenitor cells
|
DE60043534D1
(de)
|
1999-02-04 |
2010-01-28 |
Pluristem Ltd |
VERFAHREN UND VORRICHTUNG ZUR HALTUNG UND EXPANSION VON HEMATOPOIETISCHEN STAMMZELLEN UND/ODER VORLäUFERZELLEN
|
US6440682B1
(en)
*
|
1999-05-28 |
2002-08-27 |
Detroit R&D Inc. |
Detection of hypertension using immunoreactive metabolic products
|
US6787318B1
(en)
*
|
1999-06-01 |
2004-09-07 |
Roskamp Research Institute, Llc |
Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
|
US7534605B2
(en)
|
1999-06-08 |
2009-05-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
|
EP1190082A4
(de)
*
|
1999-06-25 |
2003-07-02 |
Yissum Res Dev Co |
Verfahren zur induktion von angiogenese mittels mikroorganen
|
US6875582B1
(en)
|
1999-08-19 |
2005-04-05 |
Omniscience Pharmaceuticals, Inc. |
Methods and targets of antibiotic resistance
|
US7811981B2
(en)
|
1999-08-30 |
2010-10-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
US7101839B1
(en)
|
1999-08-30 |
2006-09-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
US6998232B1
(en)
|
1999-09-27 |
2006-02-14 |
Quark Biotech, Inc. |
Methods of diagnosing bladder cancer
|
AU784258B2
(en)
|
1999-11-19 |
2006-03-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Aspegillus niger beta-glucosidase gene, protein and uses thereof
|
US6544506B2
(en)
|
2000-01-05 |
2003-04-08 |
Yeda Research & Development Co. Ltd. |
Veto cells effective in preventing graft rejection and devoid of graft versus host potential
|
WO2001053323A2
(en)
*
|
2000-01-24 |
2001-07-26 |
Ramot University Authority For Applied Research & Industrial Development Ltd. |
Plants tolerant of environmental stress conditions, methods of generating same and novel polynucleotide sequence utilized thereby
|
AU785493B2
(en)
|
2000-03-27 |
2008-01-03 |
Technion Research & Development Foundation Ltd. |
Single chain class I major histo-compatibility complexes, constructs encoding same and methods of generating same
|
US20040191260A1
(en)
*
|
2003-03-26 |
2004-09-30 |
Technion Research & Development Foundation Ltd. |
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
|
IL135884A
(en)
*
|
2000-04-30 |
2005-08-31 |
Yissum Res Dev Co |
Method for measuring non-transferrin bound iron
|
HUP0300810A2
(hu)
|
2000-07-20 |
2003-08-28 |
M.G.V.S. Ltd. |
Mesterséges értranszplantátum, valamint ennek létrehozása és alkalmazása
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
EP2359853B1
(de)
|
2000-08-08 |
2013-11-06 |
Technion Research and Development Foundation, Ltd. |
Nützliche pharmazeutische Zusammensetzungen und Verfahren für Angiogenesemodulation
|
US20030114410A1
(en)
|
2000-08-08 |
2003-06-19 |
Technion Research And Development Foundation Ltd. |
Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
|
EP1683874A3
(de)
|
2000-08-29 |
2006-10-11 |
YEDA RESEARCH AND DEVELOPMENT Co. LTD. |
Verfahren zur Isolierung von Genen, die für Proteine mit spezifischer Funktion kodieren, und zur Auslese von pharmazeutisch aktiven Wirkstoffen
|
US7632522B2
(en)
*
|
2000-09-28 |
2009-12-15 |
Nanocyte Inc. |
Use of stinging cells/capsules for the delivery of active agents to keratinous substances
|
WO2002026191A2
(en)
*
|
2000-09-28 |
2002-04-04 |
Nanocyte Inc. |
Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
|
US20070281037A9
(en)
*
|
2000-09-28 |
2007-12-06 |
Nanocyte Inc. |
Sterile preparations and compositions including stinging capsules and methods of producing and using same
|
US8071740B2
(en)
|
2000-11-17 |
2011-12-06 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
EP2386319B1
(de)
|
2000-11-17 |
2013-06-05 |
Vascular Biogenics Ltd. |
Endothelzellspezifität zeigende Promotoren und Verfahren zu deren Verwendung
|
CN100577174C
(zh)
|
2000-11-24 |
2010-01-06 |
脉管生物生长有限公司 |
含有限定的氧化磷脂的组合物
|
AU2002221013A1
(en)
*
|
2000-11-30 |
2002-06-11 |
Yeda Research And Development Co..Ltd. |
Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease
|
EP1356298B1
(de)
|
2000-11-30 |
2011-05-18 |
Crawford Healthcare Holdings Limited |
Krankheitsdiagnose
|
WO2002047535A2
(en)
*
|
2000-12-14 |
2002-06-20 |
Nyxis Neurotherapies, Inc. |
High throughput assay to detect inhibitors of the map kinase pathway
|
US7087395B1
(en)
|
2001-01-16 |
2006-08-08 |
Quest Diagnostics Investments Incorporated |
Vitamin D assay
|
IL157006A0
(en)
*
|
2001-01-17 |
2004-02-08 |
Univ Ramot |
Chitinases, derived from carnivorous plants, polynucleotide sequence encoding thereof, and methods of isolating and using same
|
US20050031618A1
(en)
*
|
2001-01-31 |
2005-02-10 |
Dror Mevorach |
Induction of tolerance by apoptotic and/or necrotic cells
|
US20050202098A1
(en)
|
2001-01-31 |
2005-09-15 |
Tolaren |
Disease therapy using dying or dead cells
|
US20030003454A1
(en)
|
2001-03-23 |
2003-01-02 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
|
US6770622B2
(en)
|
2001-06-08 |
2004-08-03 |
Gary A. Jarvis |
N-terminally truncated galectin-3 for use in treating cancer
|
IL159944A0
(en)
*
|
2001-07-19 |
2004-06-20 |
Yissum Res Dev Co |
Polypeptides having carotenoid isomerase catalytic activity, nucleic acids encoding same and uses thereof
|
WO2003017817A2
(en)
|
2001-08-16 |
2003-03-06 |
Bar Ilan University |
Diagnosis, prevention and treatment of cancer
|
US7138144B2
(en)
*
|
2001-09-07 |
2006-11-21 |
Nadir Askenasy |
Method of inducing immune tolerance via blood/lymph flow-restricted bone marrow transplantation
|
US20040136972A1
(en)
|
2001-09-07 |
2004-07-15 |
Yeda Research And Development Co. Ltd. |
Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
|
US20060068405A1
(en)
*
|
2004-01-27 |
2006-03-30 |
Alex Diber |
Methods and systems for annotating biomolecular sequences
|
EP2277887A3
(de)
|
2001-10-19 |
2011-02-16 |
Vascular Biogenics Ltd. |
Polynukleotidkonstrukte, pharmazeutische Zusammensetzungen und Verfahren zur gezielten Abwärtsregulation der Angiogenese und Therapie gegen Krebs
|
AUPR842501A0
(en)
*
|
2001-10-23 |
2001-11-15 |
Epipop Pty Ltd |
A method for identification and development of therapeutic agents
|
AU2002358947A1
(en)
*
|
2001-12-05 |
2003-06-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nanoparticles containing polymeric nucleic acid homologs, pharmaceutical compositions and articles of manufacture containing same and methods of use thereof
|
US20050085432A1
(en)
*
|
2001-12-26 |
2005-04-21 |
Aviva Lapidot |
Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
|
IL152904A0
(en)
|
2002-01-24 |
2003-06-24 |
Gamida Cell Ltd |
Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
|
WO2003062404A1
(en)
|
2002-01-25 |
2003-07-31 |
Gamida-Cell Ltd. |
Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby
|
US7781396B2
(en)
*
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
US20040052928A1
(en)
*
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
US6992176B2
(en)
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
WO2003070752A2
(en)
*
|
2002-02-20 |
2003-08-28 |
Dyax Corporation |
Mhc-peptide complex binding ligands
|
AU2003214614B2
(en)
*
|
2002-03-18 |
2008-11-20 |
Gamida-Cell Ltd. |
Methods of inducing differentiation in ex vivo expanded stem cells
|
EP1519755B1
(de)
*
|
2002-03-26 |
2008-05-07 |
Nanocyte Inc. |
Nesselzellen mit expression eines exogenen polynucleotids, das ein therapeutisches, diagnostisches oder kosmetisches mittel kodiert, und diese nesselzellen verwendende verfahren, zusammensetzungen und vorrichtungen oder daraus gewonnene kapseln zur abgabe des therapeutischen, diagnostischen oder kosmetischen mittels in ein gewebe
|
US20040121442A1
(en)
*
|
2002-05-05 |
2004-06-24 |
Ilan Chet |
Fungal chitinase, polynucleotide sequences encoding same, promoters of same, and uses thereof
|
JP2005533102A
(ja)
*
|
2002-07-12 |
2005-11-04 |
イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム |
微小器官によって生物学的プロセスを誘発する方法と装置
|
EP2561889A3
(de)
|
2002-08-01 |
2013-04-03 |
Yeda Research and Development Co. Ltd. |
Methode und Zusammensetzung zum Schutz von neuronalem Gewebe vor durch erhöhte Glutamat-Konzentrationen induzierter Schädigung
|
US7267981B2
(en)
|
2002-10-07 |
2007-09-11 |
Technion Research & Development Foundation Ltd. |
Human foreskin fibroblasts for culturing ES cells
|
WO2004037204A2
(en)
*
|
2002-10-25 |
2004-05-06 |
University Of South Florida |
Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease
|
EP1578999B1
(de)
|
2002-10-30 |
2013-01-16 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Verfahren zur messung von nichttransferringebundenem eisen
|
US20050054097A1
(en)
*
|
2002-11-17 |
2005-03-10 |
Tony Peled |
EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
|
WO2004050826A2
(en)
*
|
2002-11-29 |
2004-06-17 |
Technion Research & Development Foundation Ltd. |
Method of dynamically culturing embryonic stem cells
|
US7491699B2
(en)
*
|
2002-12-09 |
2009-02-17 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures and methods of generating and using the same
|
CN100402016C
(zh)
|
2002-12-12 |
2008-07-16 |
R.B.T(洛东生物科技)有限公司 |
木质素过氧化物酶的生产方法及其在皮肤和毛发增亮中的应用
|
AU2003303071B2
(en)
|
2002-12-16 |
2009-04-23 |
Technion Research & Development Foundation Ltd. |
Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same
|
WO2004060135A2
(en)
|
2003-01-02 |
2004-07-22 |
Rappaport Family Institute For Research In The Medical Sciences |
Methods of predicting a benefit of antioxidant therapy for prevention of cardiovascular disease in hyperglycemic patients
|
EP2058275A1
(de)
|
2003-01-07 |
2009-05-13 |
Ramot at Tel-Aviv University Ltd. |
Peptidnanostrukturen mit einem verkapselten Fremdstoff und Verfahren zu ihrer Herstellung
|
EP1599598A4
(de)
|
2003-03-04 |
2007-08-08 |
Yeda Res & Dev |
Pon-polypeptide, diese codierende polynukleotide und zusammensetzungen und verfahren unter verwendung davon
|
EP1601759A4
(de)
*
|
2003-03-07 |
2007-02-14 |
Gamida Cell Ltd |
Expansion erneuerbarer stammzellpopulationen unter verwendung von modulatoren der pi-3-kinase
|
US8017113B2
(en)
|
2003-03-12 |
2011-09-13 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions and methods for diagnosing and treating an inflammation
|
US7294701B2
(en)
*
|
2003-04-02 |
2007-11-13 |
Technion Research & Development Foundation Ltd. |
Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
|
EP1610678B1
(de)
|
2003-04-04 |
2011-07-27 |
Yeda Research And Development Co., Ltd. |
Antikörper zur hemmung der aktivität von mmp-2 und mmp-9
|
WO2004090120A2
(en)
|
2003-04-08 |
2004-10-21 |
Yeda Research And Development Co. Ltd |
Stem cells having increased sensitivity to sdf-1 and methods of generating and using same
|
FR2853551B1
(fr)
|
2003-04-09 |
2006-08-04 |
Lab Francais Du Fractionnement |
Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
|
US7321065B2
(en)
*
|
2003-04-18 |
2008-01-22 |
The Regents Of The University Of California |
Thyronamine derivatives and analogs and methods of use thereof
|
EP1625199B1
(de)
|
2003-05-22 |
2015-03-11 |
Evogene Ltd. |
Verfahren zur erhöhung der abiotischen stresstoleranz und/oder biomasse in pflanzen und damit erzeugte pflanzen
|
AU2005234725B2
(en)
|
2003-05-22 |
2012-02-23 |
Evogene Ltd. |
Methods of Increasing Abiotic Stress Tolerance and/or Biomass in Plants and Plants Generated Thereby
|
US7554007B2
(en)
*
|
2003-05-22 |
2009-06-30 |
Evogene Ltd. |
Methods of increasing abiotic stress tolerance and/or biomass in plants
|
US20050020499A1
(en)
*
|
2003-05-27 |
2005-01-27 |
Bar Ilan University |
Methods of attenuating cocaine seeking behavior employing glial cell-derived neurotrophic factor (GDNF) and pharmaceutical compositions and articles of manufacture suited for use in practice of the method
|
WO2004111183A2
(en)
*
|
2003-06-19 |
2004-12-23 |
Evogene Ltd. |
Plant trichome-specific promoter and leucoplast signal sequence
|
US8129514B2
(en)
*
|
2003-06-19 |
2012-03-06 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
KR101215821B1
(ko)
|
2003-06-30 |
2012-12-28 |
텔 아비브 유니버시티 퓨쳐 테크놀로지 디벨롭먼트 엘.피. |
아밀로이드 관련 질환을 진단 및 처치하기 위한 펩타이드, 그것에 대한 항체, 및 그 사용방법
|
MXPA06001722A
(es)
*
|
2003-08-14 |
2006-05-19 |
Bio Balance Corp |
Cepas de bacterias, composiciones que las incluyen y el uso de probioticos de las mismas.
|
US7625707B2
(en)
|
2003-10-02 |
2009-12-01 |
Ramot At Tel Aviv University Ltd. |
Antibacterial agents and methods of identifying and utilizing same
|
IL158287A0
(en)
|
2003-10-07 |
2004-05-12 |
Yeda Res & Dev |
Antibodies to nik, their preparation and use
|
JP4943848B2
(ja)
|
2003-10-07 |
2012-05-30 |
イエダ リサーチ アンド ディベロップメント カンパニー リミテッド |
Nikに対する抗体、その調製および使用
|
CA2542221A1
(en)
*
|
2003-10-23 |
2005-05-06 |
Pfizer Products Inc. |
Vaccine for periodontal disease
|
CA2547459C
(en)
|
2003-11-30 |
2013-10-08 |
Yeda Research And Development Co. Ltd |
Modulators of nik-siva complex formation for treating immune disorders
|
WO2005059100A2
(en)
*
|
2003-12-12 |
2005-06-30 |
New York University |
Methods and compositions relating to cystatin c
|
US20100221233A1
(en)
*
|
2003-12-15 |
2010-09-02 |
University Of South Florida |
Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers
|
WO2005061018A1
(en)
|
2003-12-22 |
2005-07-07 |
Regentis Biomaterials Ltd. |
Matrix comprising naturally-occurring protein backbone
|
US8007847B2
(en)
|
2004-01-13 |
2011-08-30 |
Eytan Biderman |
Feeding formula appliance
|
US7423139B2
(en)
*
|
2004-01-20 |
2008-09-09 |
Insight Biopharmaceuticals Ltd. |
High level expression of recombinant human erythropoietin having a modified 5′-UTR
|
JP2007526337A
(ja)
|
2004-03-02 |
2007-09-13 |
アクセルロン ファーマ インコーポレーテッド |
Alk7およびミオスタチン阻害剤ならびにその使用
|
US8352031B2
(en)
|
2004-03-10 |
2013-01-08 |
Impulse Dynamics Nv |
Protein activity modification
|
ES2635546T3
(es)
|
2004-06-14 |
2017-10-04 |
Evogene Ltd. |
Polinucleótidos y polipéptidos implicados en el desarrollo de fibra vegetal y métodos de uso de los mismos
|
US8680062B2
(en)
*
|
2004-07-06 |
2014-03-25 |
Deliversir Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
US20090156471A1
(en)
*
|
2004-07-15 |
2009-06-18 |
Ramot At Tel Aviv University Ltd. |
Use of anti-amyloid agents for treating and typing pathogen infections
|
WO2006030442A2
(en)
|
2004-09-16 |
2006-03-23 |
Gamida-Cell Ltd. |
Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells
|
US8000900B2
(en)
|
2004-09-21 |
2011-08-16 |
Microsoft Corporation |
Association-based predictions of pathogen characteristics
|
US20060095241A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Microsoft Corporation |
Systems and methods that utilize machine learning algorithms to facilitate assembly of aids vaccine cocktails
|
ES2524601T3
(es)
*
|
2004-09-29 |
2014-12-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
RNasa T2 humana recombinante y usos de la misma
|
EP3088528B1
(de)
|
2004-09-29 |
2019-07-03 |
Collplant Ltd. |
Kollagenproduzierende pflanzen und verfahren zur erzeugung und verwendung davon
|
US7781402B2
(en)
*
|
2004-10-12 |
2010-08-24 |
Closed Loop Therapies Ltd. |
Methods and implantable devices for treating supraventricular arrhythmias
|
US8478535B2
(en)
|
2004-10-29 |
2013-07-02 |
Microsoft Corporation |
Systems and methods that utilize machine learning algorithms to facilitate assembly of aids vaccine cocktails
|
US20060134680A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Alexander Kotlyar |
Homogeneous populations of nucleic acids, methods of synthesyzing same and uses thereof
|
JP2008527563A
(ja)
|
2005-01-16 |
2008-07-24 |
ズランゴー リミテッド |
アイコニック通信
|
JP2008529325A
(ja)
*
|
2005-01-16 |
2008-07-31 |
ズランゴー リミテッド |
通信ネットワークシステムおよびそれを使用するための方法
|
US8019818B2
(en)
*
|
2005-01-18 |
2011-09-13 |
Zlango Ltd. |
Communications network system and methods for using same
|
ES2562406T3
(es)
|
2005-01-31 |
2016-03-04 |
Realbio Technologies Ltd. |
Dispositivo capilar de flujo lateral de reacción multietapa
|
JP4992091B2
(ja)
|
2005-02-17 |
2012-08-08 |
ハダシット メディカル リサーチ サービシーズ アンド デベロップメント リミテッド |
子宮内膜症を治療するためのビスホスホネート
|
JP5432455B2
(ja)
|
2005-02-25 |
2014-03-05 |
ザ ステート オブ イスラエル、ミニストリー オブ アグリカルチャー アンド ルーラル ディベロップメント、アグリカルチュラル リサーチ オーガナイゼイション、(エー.アール.オー.)、ボルカニ センター |
炎症治療用の果実細胞培養抽出物
|
US7695927B2
(en)
*
|
2005-03-18 |
2010-04-13 |
Detroit R & D |
Detection of hypertension using glucuronidated metabolic products
|
EP1874334A4
(de)
*
|
2005-04-15 |
2011-03-30 |
Vascular Biogenics Ltd |
Zusammensetzungen mit von beta 2-glykoprotein i stammenden peptiden zur prävention und/oder behandlung von gefässerkrankungen
|
US8834862B2
(en)
*
|
2005-04-19 |
2014-09-16 |
Nanocyte Inc. |
Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
|
CA2609702C
(en)
*
|
2005-04-28 |
2013-05-28 |
Ventana Medical Systems, Inc. |
Antibody conjugates via heterobifunctional peg linkers
|
EP1893241A2
(de)
*
|
2005-04-28 |
2008-03-05 |
Ventana Medical Systems, Inc. |
Mit antikörpern über einen peg-linker konjugierte fluoreszierende nanopartikel
|
EP2279726A3
(de)
|
2005-05-26 |
2012-06-20 |
Biorest Ltd. |
Zusammensetzungen und diese verwende Verfahren zur Abgabe von Mitteln in ein Zielorgan geschützt durch eine Blutbarriere
|
WO2006134602A2
(en)
|
2005-06-16 |
2006-12-21 |
Ramot At Tel Aviv University Ltd. |
Isolated cells and populations comprising same for the treatment of cns diseases
|
US20070225242A1
(en)
*
|
2005-06-21 |
2007-09-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method and composition for treating and preventing tumor metastasis in vivo
|
JP5383186B2
(ja)
*
|
2005-07-07 |
2014-01-08 |
イッサム リサーチ ディベロプメント カンパニー オブ ザ ヘブリュー ユニバーシティ オブ エルサレム リミテッド |
H19をダウンレギュレートする核酸薬剤、及びそれを使用する方法
|
CA2613619A1
(en)
|
2005-07-07 |
2007-01-18 |
Fulcrum Sp Ltd. |
Sp1 polypeptides, modified sp1 polypeptides and uses thereof
|
BRPI0616012A2
(pt)
|
2005-07-18 |
2011-05-31 |
Protalix Ltd |
administração via mucosa ou intestino de macromoléculas biologicamente ativas
|
CA2616766A1
(en)
|
2005-07-26 |
2007-02-01 |
University Of Medicine And Dentistry Of New Jersey |
Antibody profiles characteristic of tuberculosis state
|
JP2009504659A
(ja)
*
|
2005-08-08 |
2009-02-05 |
オンコノン・リミテッド・ライアビリティ・カンパニー |
抗体組成物、腫瘍性疾患の処置方法、および受胎能の調節方法
|
US8916147B2
(en)
|
2005-08-24 |
2014-12-23 |
Yeda Research and Devolpment Co. Ltd. |
Universal donor-derived tolerogenic cells for inducing non-syngeneic transplantation tolerance
|
EP1962719A4
(de)
|
2005-08-29 |
2011-05-04 |
Technion Res And Dev Of Foundation Ltd |
Medien zur züchtung von stammzellen
|
US8034914B2
(en)
*
|
2005-09-22 |
2011-10-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nucleic acid constructs, pharmaceutical compositions and methods of using same for treating cancer
|
US20070087437A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Jifan Hu |
Methods for rejuvenating cells in vitro and in vivo
|
RU2425151C2
(ru)
|
2005-10-24 |
2011-07-27 |
Эвоген Лтд. |
Изолированные полипептиды, кодирующие их полинуклеотиды, экспрессирующие их трансгенные растения и способы их использования
|
EP1950166B1
(de)
*
|
2005-11-18 |
2014-05-07 |
Mitsubishi Denki Kabushiki Kaisha |
Vorrichtung zur beleuchtung einer aufzugskabine
|
ES2677555T3
(es)
*
|
2005-11-23 |
2018-08-03 |
Ventana Medical Systems, Inc. |
Conjugado molecular
|
BRPI0620523A2
(pt)
|
2005-11-29 |
2011-11-16 |
Gamida Cell Ltd |
método de aumentar o potencial de implante e de atração celular, método de preparar células para transplante em um sujeito, população de células e composição farmacêutica
|
US8846393B2
(en)
|
2005-11-29 |
2014-09-30 |
Gamida-Cell Ltd. |
Methods of improving stem cell homing and engraftment
|
EP2237037A1
(de)
|
2005-12-12 |
2010-10-06 |
Gyros Patent Ab |
Mikrofluid-Vorrichtung und deren Verwendung
|
US20070134739A1
(en)
*
|
2005-12-12 |
2007-06-14 |
Gyros Patent Ab |
Microfluidic assays and microfluidic devices
|
US8775526B2
(en)
|
2006-01-16 |
2014-07-08 |
Zlango Ltd. |
Iconic communication
|
US7553941B2
(en)
*
|
2006-02-03 |
2009-06-30 |
Modigene Inc |
Long-acting polypeptides and methods of producing same
|
US10351615B2
(en)
|
2006-02-03 |
2019-07-16 |
Opko Biologics Ltd. |
Methods of treatment with long-acting growth hormone
|
US8759292B2
(en)
|
2006-02-03 |
2014-06-24 |
Prolor Biotech, Llc |
Long-acting coagulation factors and methods of producing same
|
US20150038413A1
(en)
|
2006-02-03 |
2015-02-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US9458444B2
(en)
|
2006-02-03 |
2016-10-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US8476234B2
(en)
|
2006-02-03 |
2013-07-02 |
Prolor Biotech Inc. |
Long-acting coagulation factors and methods of producing same
|
US10221228B2
(en)
|
2006-02-03 |
2019-03-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8048849B2
(en)
|
2006-02-03 |
2011-11-01 |
Modigene, Inc. |
Long-acting polypeptides and methods of producing same
|
US9249407B2
(en)
|
2006-02-03 |
2016-02-02 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US8946155B2
(en)
|
2006-02-03 |
2015-02-03 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US20140113860A1
(en)
|
2006-02-03 |
2014-04-24 |
Prolor Biotech Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8048848B2
(en)
|
2006-02-03 |
2011-11-01 |
Prolor Biotech Ltd. |
Long-acting interferons and derivatives thereof and methods thereof
|
US8450269B2
(en)
|
2006-02-03 |
2013-05-28 |
Prolor Biotech Ltd. |
Long-acting growth hormone and methods of producing same
|
US20090197286A1
(en)
|
2006-02-06 |
2009-08-06 |
Rappaport Family Institute For Research In The Med |
Methods and Kit for Diagnosing T1DM
|
WO2007102146A2
(en)
|
2006-03-06 |
2007-09-13 |
Zetiq Technologies Ltd. |
Methods and compositions for identifying a cell phenotype
|
MX2008012085A
(es)
|
2006-03-23 |
2009-01-22 |
Pluristem Ltd |
Metodos para expansion de celulas y usos de celulas y medios acondicionados producidos de esta manera para terapia.
|
US20090226909A1
(en)
|
2006-03-28 |
2009-09-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods and kits for Determining Predisposition to Warfarin Resistance
|
EP2010567A2
(de)
*
|
2006-04-07 |
2009-01-07 |
The Government of the United States of America as Represented by The Department of Health and Human Services |
Antikörperzusammensetzungen und verfahren zur behandlung von neoplasien
|
WO2007136778A2
(en)
*
|
2006-05-19 |
2007-11-29 |
Teva Pharmaceutical Industries, Ltd. |
Fusion proteins, uses thereof and processes for producing same
|
US20070281883A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Hanna Rosenfeld |
Development of follicle stimulating hormone agonists and antagonists in fish
|
WO2008010228A2
(en)
|
2006-07-20 |
2008-01-24 |
Yeda Research And Development Co. Ltd. |
Photosyntheticorganisms and compositions and methods of generating same
|
EP2064319B1
(de)
|
2006-08-28 |
2017-02-22 |
Yeda Research and Development Co. Ltd. |
Verfahren zur erzeugung von glia- und neuronalen zellen und verwendung davon für die behandlung medizinischer leiden des zns
|
US7888059B2
(en)
*
|
2006-10-05 |
2011-02-15 |
Yeda Research And Development Co. Ltd. |
Highly purified and stabilized Na,K-ATPase isoforms and methods of producing same
|
WO2008041183A2
(en)
|
2006-10-05 |
2008-04-10 |
Technion Research & Development Foundation Ltd. |
Microtubes and methods of producing same
|
EP2096909A4
(de)
*
|
2006-12-20 |
2010-08-04 |
Evogene Ltd |
An der entwicklung von pflanzenfasern beteiligte polynukleotide und polypeptide sowie verfahren zur verwendung davon
|
CA2675967A1
(en)
*
|
2007-01-16 |
2008-07-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusale M |
Nucleic acid constructs and methods for specific silencing of h19
|
US20100196403A1
(en)
*
|
2007-01-29 |
2010-08-05 |
Jacob Hochman |
Antibody conjugates for circumventing multi-drug resistance
|
US8911996B2
(en)
|
2007-01-31 |
2014-12-16 |
Technion Research & Development Foundation Limited |
Electrospun scaffolds and methods of generating and using same
|
US8546333B2
(en)
|
2007-02-01 |
2013-10-01 |
Technion Research & Development Foundation Limited |
Albumin fibers and fabrics and methods of generating and using same
|
EP2839839B1
(de)
|
2007-02-28 |
2018-01-17 |
Yeda Research And Development Company Limited |
Nuklear-Targeting-Sequenzen
|
EP2514766A3
(de)
|
2007-03-29 |
2013-06-05 |
Technion Research & Development Foundation Ltd. |
Antikörper, Verfahren und Kits zur Diagnose und Behandlung von Melanomen
|
JP2010523104A
(ja)
|
2007-04-02 |
2010-07-15 |
ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド |
ガン細胞検出方法ならびにガン疾患の診断およびガン疾患の処置のモニタリングのためのその使用
|
MX355608B
(es)
|
2007-04-09 |
2018-04-24 |
Evogene Ltd |
Polinucleotidos, polipeptidos y metodos para aumentar el contenido de aceite, la velocidad de crecimiento y biomasa de las plantas.
|
US9156865B2
(en)
|
2007-04-23 |
2015-10-13 |
Deliversir Ltd |
System for delivering therapeutic agents into living cells and cells nuclei
|
WO2008129548A2
(en)
*
|
2007-04-23 |
2008-10-30 |
Segev Laboratories Limited |
A system for delivering therapeutic agents into living cells and cells nuclei
|
US9556210B2
(en)
|
2007-04-23 |
2017-01-31 |
Sabag-Rfa Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
WO2008132753A2
(en)
|
2007-05-01 |
2008-11-06 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods and kits for detecting fetal cells in the maternal blood
|
JP2010530735A
(ja)
|
2007-05-03 |
2010-09-16 |
エージェンシー フォー サイエンス,テクノロジー アンド リサーチ |
細胞内のprl−1ポリペプチドまたはprl−3ポリペプチドに結合する抗体
|
DK2150608T3
(en)
|
2007-05-07 |
2018-03-12 |
Protalix Ltd |
LARGE-SCALE ENTRY BIOR ACTOR
|
ATE540115T1
(de)
|
2007-07-11 |
2012-01-15 |
Yeda Res & Dev |
Nukleinsäurekonstruktsysteme mit fähigkeit zur diagnose oder behandlung eines zellzustands
|
IL184627A0
(en)
|
2007-07-15 |
2008-12-29 |
Technion Res & Dev Foundation |
Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
|
AU2008277257B2
(en)
|
2007-07-15 |
2014-03-06 |
Hillman, Yitzchak Mr |
Disease treatment via antimicrobial peptides or their inhibitors
|
BR122020022203B1
(pt)
|
2007-07-24 |
2021-04-20 |
Evogene Ltd |
método de aumento da taxa de crescimento de uma planta
|
CN101835490A
(zh)
|
2007-08-02 |
2010-09-15 |
阿雷斯托生物科学股份有限公司 |
Lox和loxl2抑制剂及其应用
|
KR20100071972A
(ko)
|
2007-08-15 |
2010-06-29 |
예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 |
Mmp-9의 조절인자 및 그의 용도
|
WO2009034574A2
(en)
|
2007-09-12 |
2009-03-19 |
Yeda Research And Development Co. Ltd. |
Methods of treating tumors in immune-privileged sites
|
EP3103463B1
(de)
|
2007-09-19 |
2020-01-01 |
Pluristem Ltd. |
Adhärente zellen aus fett- oder plazentagewebe und verwendung davon in der therapie
|
EP2781223B1
(de)
|
2007-10-19 |
2017-02-22 |
Rappaport Family Institute for Research in the Medical Sciences |
Zusammensetzungen mit Semaphorinen zur Verwendung in der Behandlung von Krebserkrankungen
|
EP2599790A1
(de)
|
2007-11-26 |
2013-06-05 |
Yissum Research Development Company of The Hebrew University of Jerusalem |
Zusammensetzungen mit faserigen Polypeptiden und Polysacchariden
|
CA2709517C
(en)
|
2007-12-27 |
2019-02-26 |
Evogene Ltd. |
Isolated polypeptides, polynucleotides useful for modifying water use efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants
|
AU2009208607B2
(en)
*
|
2008-01-31 |
2013-08-01 |
Compugen Ltd. |
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
|
WO2009104175A2
(en)
|
2008-02-21 |
2009-08-27 |
Technion Research & Development Foundation Ltd. |
Use of electrospun microtubes for drug delivery
|
EP2297200A1
(de)
*
|
2008-04-09 |
2011-03-23 |
Technion Research & Development Foundation Ltd. |
Anti-influenza-antikörper und anwendungen davon
|
US8747855B2
(en)
*
|
2008-04-09 |
2014-06-10 |
Technion Research & Development Foundation Limited |
Anti human immunodeficiency antibodies and uses thereof
|
CN102083615B
(zh)
*
|
2008-04-10 |
2014-08-13 |
战略系统有限公司 |
用于三维模型打印的系统和方法
|
CN104491845A
(zh)
|
2008-04-18 |
2015-04-08 |
科尔普兰特有限公司 |
产生和使用原胶原的方法
|
MX2010011511A
(es)
|
2008-04-21 |
2011-06-09 |
Danziger Innovations Ltd |
Vectores de expresion viral de planta y uso de los mismos para generar variaciones genotipicas en genomas de plantas.
|
JP2010043063A
(ja)
|
2008-05-09 |
2010-02-25 |
Agency For Science Technology & Research |
川崎病の診断及び治療
|
WO2009141824A2
(en)
|
2008-05-22 |
2009-11-26 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficieny
|
AU2009252722A1
(en)
|
2008-05-27 |
2009-12-03 |
Pluristem Ltd. |
Methods of treating inflammatory colon diseases
|
US8663987B2
(en)
|
2008-05-28 |
2014-03-04 |
Ramot At Tel-Aviv University Ltd. |
Mesenchymal stem cells for the treatment of CNS diseases
|
US9952211B2
(en)
|
2008-06-29 |
2018-04-24 |
Realbio Technologies Ltd. |
Liquid-transfer device particularly useful as a capturing device in a biological assay process
|
JP5583667B2
(ja)
|
2008-08-08 |
2014-09-03 |
ジェニスフィア・エルエルシー |
長時間作用型dnaデンドリマーおよびその方法
|
EP2331107A4
(de)
|
2008-08-08 |
2011-08-24 |
Agency Science Tech & Res |
Vhz für diagnose und behandlung von tumoren
|
CA2732773C
(en)
|
2008-08-18 |
2019-08-27 |
Evogene Ltd. |
Isolated polypeptides and polynucleotides useful for increasing nitrogen use efficiency, abiotic stress tolerance, yield and biomass in plants
|
AU2009288781B2
(en)
|
2008-09-02 |
2015-01-29 |
Pluri Biotech Ltd |
Adherent cells from placenta tissue and use thereof in therapy
|
US8367392B2
(en)
*
|
2008-09-05 |
2013-02-05 |
Transalgae Ltd. |
Genetic transformation of algal and cyanobacteria cells by microporation
|
US20110305682A1
(en)
|
2008-09-11 |
2011-12-15 |
Ben Gurion University Of The Negev Research And Development Authority |
Compositions and Methods for Treating S. Pneumonia Infection
|
EP2331679B1
(de)
|
2008-09-12 |
2017-04-19 |
Cryopraxis Criobiologia LTDA. |
Ischämische gewebezellentherapie
|
EP2344521B1
(de)
|
2008-09-24 |
2019-08-21 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Peptide und zusammensetzungen zur prävention von zellenadhäsion und verfahren zu deren verwendung
|
CA2736729A1
(en)
|
2008-09-29 |
2010-04-01 |
Ben Gurion University Of The Negev Research And Development Authority |
Amyloid beta-peptides and methods of use thereof
|
BRPI0914522B1
(pt)
|
2008-10-30 |
2019-04-02 |
Evogene Ltd |
Método para aumentar o rendimento, a biomassa, a taxa de crescimento, o vigor, oteor de óleo, e/ou a eficiência da utilização do nitrogênio de uma planta
|
WO2010055525A1
(en)
|
2008-11-17 |
2010-05-20 |
Technion Research & Development Foundation Ltd. |
Method for predicting a patient's responsiveness to anti-folate therapy
|
WO2010058396A1
(en)
|
2008-11-19 |
2010-05-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
A cd44vra antibody and diagnostic and therapeutic methods using same
|
WO2010061383A1
(en)
|
2008-11-26 |
2010-06-03 |
Biodalia Microbiological Technologies Ltd. |
A method of in-situ enrichment of foods with fructan
|
WO2010064231A1
(en)
|
2008-12-02 |
2010-06-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods of analyzing a-i rna editing and nucleic acid constructs capable of same
|
US20120014927A1
(en)
|
2008-12-03 |
2012-01-19 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods and kits for determining predisposition to cancer
|
ES2554765T3
(es)
|
2008-12-05 |
2015-12-23 |
Yeda Research And Development Co. Ltd. |
miRNA-9 o miRNA-9* para uso en el tratamiento de ELA
|
WO2010071610A1
(en)
|
2008-12-19 |
2010-06-24 |
Agency For Science, Technology And Research (A*Star) |
Severe chikungunya biomarkers
|
KR101383408B1
(ko)
|
2008-12-29 |
2014-04-17 |
텔 하쇼머 메디컬 리서치 인프라스트럭쳐 앤드 서비시스 리미티드. |
세포 유착 방지를 위한 펩티드와 조성물 및 그것의 사용 방법
|
US8952218B2
(en)
|
2008-12-29 |
2015-02-10 |
Evogene Ltd. |
Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance, biomass and/or yield in plants expressing same
|
WO2010076788A2
(en)
|
2008-12-29 |
2010-07-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of predicting responsiveness to interferon treatment and treating hepatitis c infection
|
WO2010076794A1
(en)
|
2008-12-31 |
2010-07-08 |
Technion Research & Development Foundation Ltd. |
Method of denitrifying brine and systems capable of same
|
US9107935B2
(en)
|
2009-01-06 |
2015-08-18 |
Gilead Biologics, Inc. |
Chemotherapeutic methods and compositions
|
IL196820A0
(en)
|
2009-02-01 |
2009-11-18 |
Yissum Res Dev Co |
Devitalized, acellular scaffold matrices derived from micro-organs seeded with various cells
|
CN102369015A
(zh)
|
2009-02-02 |
2012-03-07 |
雷蒙特亚特特拉维夫大学有限公司 |
肽、包含该肽的药物组合物及其用途
|
WO2010089707A1
(en)
|
2009-02-04 |
2010-08-12 |
Yeda Research And Development Co. Ltd. |
Methods and kits for determining sensitivity or resistance of prostate cancer to radiation therapy
|
EP2401362B1
(de)
|
2009-02-26 |
2017-04-12 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Isolierte populationen von nierenstammzellen und verfahren zur isolierung und verwendung davon
|
EP3000889B1
(de)
|
2009-03-02 |
2018-12-05 |
Evogene Ltd. |
Isolierte polynukleotide und polypeptide sowie verfahren zu ihrer verwendung zur erhöhung des ertrags oder zur verbesserung der landwirtschaftlichen eigenschaften von pflanzen
|
DK2406279T3
(en)
|
2009-03-09 |
2016-04-25 |
Univ Ramot |
Compositions for prevention and treatment of neurodegenerative diseases
|
WO2010103517A1
(en)
|
2009-03-12 |
2010-09-16 |
Rappaport Family Institute For Research In The Medical Sciences |
Soluble compositions for the treatment of cxcr3-ligand associated diseases
|
DK2414542T3
(da)
|
2009-03-30 |
2017-11-27 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Fremgangsmåder til forudsigelse af klinisk forløb for og behandling af multipel sklerose
|
EP2344179A1
(de)
|
2009-04-01 |
2011-07-20 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Verfahren zur steuerung der proliferation und differenzierung von keratinozyten
|
WO2010116375A1
(en)
|
2009-04-08 |
2010-10-14 |
Yeda Research And Development Co. Ltd. |
Isolated peptides for regulating apoptosis
|
WO2010125571A1
(en)
|
2009-04-30 |
2010-11-04 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Anti ceacam1 antibodies and methods of using same
|
WO2010134073A1
(en)
|
2009-05-19 |
2010-11-25 |
Zetiq Technologies Ltd. |
Kits for and methods of differential staining of cervical cancer cells and/or tissues
|
WO2010137017A2
(en)
|
2009-05-27 |
2010-12-02 |
Yeda Research And Development Co. Ltd. |
Proteasome inhibitors and uses thereof
|
WO2010137013A1
(en)
|
2009-05-27 |
2010-12-02 |
Ramot At Tel Aviv University Ltd. |
Crystallized photosystem i units from the pea plant and their use in solid state devices
|
US20120078163A1
(en)
|
2009-05-27 |
2012-03-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of generating connective tissue
|
EP2435078A1
(de)
|
2009-05-28 |
2012-04-04 |
Yeda Research and Development Co. Ltd. |
Verfahren zur behandlung von entzündungen
|
BRPI1009032B1
(pt)
|
2009-06-10 |
2019-05-28 |
Evogene Ltd. |
Método de aumento de eficiência no uso de nitrogênio, biomassa, taxa de crescimento, e/ou tolerância a deficiência de nitrogênio de uma planta
|
WO2010150259A1
(en)
|
2009-06-24 |
2010-12-29 |
Fund For Medical Research Development Of Infrastructure And Health Services -Rambam Medical Center |
Methods and kits for isolating placental derived microparticles and use of same for diagnosis of fetal disorders
|
US9663778B2
(en)
|
2009-07-09 |
2017-05-30 |
OPKO Biologies Ltd. |
Long-acting coagulation factors and methods of producing same
|
WO2011004379A1
(en)
|
2009-07-10 |
2011-01-13 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Compositions and methods for treating cancer
|
CA2768725A1
(en)
|
2009-07-21 |
2011-01-27 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
A method of diagnosing cancer
|
GB0913442D0
(en)
|
2009-07-31 |
2009-09-16 |
Univ Ramot |
Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
|
WO2011021194A2
(en)
|
2009-08-17 |
2011-02-24 |
Technion Research & Development Foundation Ltd. |
Pericyte progenitor cells and methods of generating and using same
|
WO2011021171A1
(en)
|
2009-08-21 |
2011-02-24 |
Beeologics, Llc |
Preventing and curing beneficial insect diseases via plant transcribed molecules
|
JP2013502228A
(ja)
*
|
2009-08-21 |
2013-01-24 |
ギリアド バイオロジクス,インク. |
invitroスクリーニングアッセイ
|
SG2014004816A
(en)
|
2009-08-21 |
2014-03-28 |
Gilead Biologics Inc |
Catalytic domains from lysyl oxidase and loxl2
|
CN102596179A
(zh)
|
2009-08-27 |
2012-07-18 |
工业研究与发展基金会有限公司 |
脂质体组合物及其用途
|
WO2011030336A1
(en)
|
2009-09-08 |
2011-03-17 |
Ramot At Tel-Aviv University Ltd. |
Methods of diagnosing amyotrophic lateral sclerosis (als)
|
US9610331B2
(en)
|
2009-09-08 |
2017-04-04 |
Yeda Research And Development Co. Ltd. |
Methods for hematopoietic precursor mobilization
|
US20120171213A1
(en)
|
2009-09-10 |
2012-07-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating tumors
|
US8735124B2
(en)
|
2009-09-17 |
2014-05-27 |
Yeda Research And Development Co. Ltd. |
Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
WO2011033506A2
(en)
|
2009-09-17 |
2011-03-24 |
Yeda Research And Development Co. Ltd. |
Isolated pon1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
CA2773935C
(en)
|
2009-09-17 |
2018-06-19 |
Ramot At Tel Aviv University Ltd. |
Peptides for the treatment of oxidative stress related disorders
|
US20110081706A1
(en)
*
|
2009-10-02 |
2011-04-07 |
TransAlgae Ltd |
Method and system for efficient harvesting of microalgae and cyanobacteria
|
US8962584B2
(en)
|
2009-10-14 |
2015-02-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Compositions for controlling Varroa mites in bees
|
MX353880B
(es)
|
2009-10-14 |
2018-01-31 |
Yissum Research Development Company Of The Hebrew Univ Of Jerusalem Ltd Star |
Composiciones para controlar ácaros varroa en abejas.
|
JP2013508013A
(ja)
|
2009-10-16 |
2013-03-07 |
ザ ユニバーシティ オブ メディスン アンド デンティストリー オブ ニュー ジャージー |
細胞療法戦略を用いた慢性神経組織損傷の治療方法
|
WO2011048600A1
(en)
|
2009-10-21 |
2011-04-28 |
Danziger Innovations Ltd. |
Generating genotypic variations in plant genomes by gamete infection
|
IL201999A
(en)
|
2009-11-08 |
2017-10-31 |
Medical Res & Development Fund For Health Services Bnai Zion Medical Center The State Of Israel |
A knockout mouse of the 1 – mo gene, a gene associated with morbidly extreme obesity
|
WO2011058557A1
(en)
|
2009-11-12 |
2011-05-19 |
Ramot At Tel-Aviv University Ltd. |
Compositions comprising pedf and uses of same in the treatment and prevention of ovary-related syndromes
|
WO2011058555A1
(en)
|
2009-11-12 |
2011-05-19 |
Yeda Research And Development Co. Ltd. |
A method of editing dna in a cell and constructs capable of same
|
EP2499236B1
(de)
|
2009-11-12 |
2020-01-01 |
Technion Research & Development Foundation Ltd. |
Kulturmedien, zellkulturen und verfahren zur kultivierung pluripotenter stammzellen in undifferenziertem zustand
|
US20120230974A1
(en)
|
2009-11-17 |
2012-09-13 |
Protalix Ltd |
Alkaline alpha galactosidase for the treatment of fabry disease
|
EP2504472A1
(de)
|
2009-11-24 |
2012-10-03 |
Collplant Ltd. |
Verfahren zur erzeugung von kollagenfasern
|
US9175262B2
(en)
|
2009-11-30 |
2015-11-03 |
Pluristerm Ltd. |
Adherent cells from placenta and use of same in disease treatment
|
WO2011067745A2
(en)
|
2009-12-06 |
2011-06-09 |
Rosetta Green Ltd. |
Compositions and methods for enhancing plants resistance to abiotic stress
|
EP2510098B1
(de)
|
2009-12-09 |
2015-02-11 |
Quark Pharmaceuticals, Inc. |
Verfahren und zusammensetzungen und zur behandlung von erkrankungen, störungen oder läsionen des zns
|
EP3056569A3
(de)
|
2009-12-28 |
2016-10-19 |
Evogene Ltd. |
Isolierte polynukleotide und polypeptide sowie verfahren zur verwendung davon zur erhöhung von pflanzenertrag, biomasse, wachstumsrate, stärke, ölgehalt, abiotischer stresstoleranz von pflanzen und der stickstoffverbrauchseffizienz
|
CA2785627C
(en)
|
2009-12-29 |
2020-02-18 |
Gamida-Cell Ltd. |
Methods for enhancing natural killer cell proliferation and activity
|
AU2011204405B2
(en)
|
2010-01-05 |
2015-06-18 |
Vascular Biogenics Ltd. |
Methods for use of a specific anti-angiogenic adenoviral agent
|
SG10201500015TA
(en)
|
2010-01-12 |
2015-02-27 |
Vascular Biogenics Ltd |
Methods of producing adenovirus vectors and viral preparations generated thereby
|
EP2528949A1
(de)
|
2010-01-27 |
2012-12-05 |
Yeda Research And Development Co. Ltd. |
Antikörper zur hemmung von metalloproteinen
|
RU2549684C2
(ru)
|
2010-02-04 |
2015-04-27 |
Джилид Байолоджикс, Инк. |
Антитела, связывающиеся с лизилоксидазоподобным ферментом-2 (loxl2), и способы их применения
|
US9410131B2
(en)
|
2010-02-11 |
2016-08-09 |
Yeda Research And Development Co. Ltd. |
Enzymatic systems for carbon fixation and methods of generating same
|
WO2011104708A2
(en)
|
2010-02-24 |
2011-09-01 |
Ben Gurion University Of The Negev Research And Development Authority |
Methods for inhibiting necrosis
|
WO2011107939A1
(en)
|
2010-03-01 |
2011-09-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of predicting efficacy of an anti-vegfa treatment for solid tumors
|
WO2011107994A1
(en)
|
2010-03-04 |
2011-09-09 |
Yeda Research And Development Co. Ltd. |
Methods of measuring protein stability
|
EA201792402A3
(ru)
|
2010-03-08 |
2018-09-28 |
Монсанто Текнолоджи Ллс |
Молекулы полинуклеотидов для регуляции генов у растений
|
US9267142B2
(en)
|
2010-03-08 |
2016-02-23 |
Yeda Research And Development Co. Ltd. |
Recombinant protein production in heterologous systems
|
WO2011111050A2
(en)
|
2010-03-11 |
2011-09-15 |
Jacob Edrei |
Methods of generating hydrogen
|
WO2011125015A2
(en)
|
2010-04-05 |
2011-10-13 |
Bar-Ilan University |
Protease-activatable pore-forming polypeptides
|
US8927274B2
(en)
|
2010-04-12 |
2015-01-06 |
Technion Research & Development Foundation Limited |
Populations of pancreatic progenitor cells and methods of isolating and using same
|
EP2557913B1
(de)
|
2010-04-12 |
2016-08-03 |
Ben Gurion University Of The Negev Research And Development Authority |
Sulfotransferase einer roten mikroalge und verwendungen davon
|
EP2561356B1
(de)
|
2010-04-18 |
2016-08-03 |
Yeda Research and Development Co. Ltd. |
Moleküle und deren verwendung zur behandlung von erbb/erbb liganden - assozierten krankheiten
|
EP2563112A4
(de)
|
2010-04-28 |
2014-03-05 |
Evogene Ltd |
Isolierte polynukleotide und polypeptide sowie verfahren zu ihrer verwendung zur erhöhung des ertrags oder zur verbesserung der landwirtschaftlichen eigenschaften von pflanzen
|
US20130053277A1
(en)
|
2010-05-04 |
2013-02-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of identifying inhibitors of polypeptides-of-interest
|
EP2566500B1
(de)
|
2010-05-05 |
2017-04-12 |
Rappaport Family Institute for Research in the Medical Sciences |
Ccl1 zur verwendung für therapeutische zwecke
|
IL208820A0
(en)
|
2010-10-19 |
2011-01-31 |
Rachel Teitelbaum |
Biologic female contraceptives
|
WO2011141914A1
(en)
|
2010-05-13 |
2011-11-17 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Isolated populations of adult renal cells and methods of isolating and using same
|
ES2410754T3
(es)
|
2010-05-25 |
2013-07-03 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Procedimiento para la detección electroquímica de reacciones de unión
|
CA2800257C
(en)
*
|
2010-05-26 |
2019-03-05 |
The Board Of Trustees Of The University Of Illinois |
Personal glucose meters for detection and quantification of a broad range of analytes
|
CN103037891A
(zh)
|
2010-06-03 |
2013-04-10 |
雷蒙特亚特特拉维夫大学有限公司 |
治疗糖尿病的方法和能够治疗糖尿病的组合物
|
AU2011263306A1
(en)
|
2010-06-07 |
2013-01-10 |
Osnat Ashur-Fabian |
Methods and kits for diagnosing conditions related to hypoxia
|
US9187787B2
(en)
|
2010-06-16 |
2015-11-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of diagnosing and treating cancer
|
CN103154022A
(zh)
|
2010-06-16 |
2013-06-12 |
富途锐基尼以色列有限公司 |
抗害虫植物
|
ES2817780T3
(es)
|
2010-07-12 |
2021-04-08 |
The State Of Israel Ministry Of Agriculture And Rural Development Agricultural Res Organization A R |
Polinucleótidos aislados y métodos y plantas que usan los mismos para regular la acidez de las plantas
|
WO2012007951A1
(en)
|
2010-07-15 |
2012-01-19 |
Technion Research & Development Foundation Ltd. |
Isolated high affinity entities with t-cell receptor like specificity towards native complexes of mhc class ii and glutamic acid decarboxylase (gad) autoantigenic peptides
|
EP2593480A2
(de)
|
2010-07-15 |
2013-05-22 |
Technion Research & Development Foundation Ltd. |
Antikörper mit t-zell-rezeptorähnlicher spezifität gegenüber nativen komplexen der mhc-klasse ii und diabetes-assoziierten autoantigenen peptiden
|
CA2804728A1
(en)
|
2010-07-15 |
2012-01-19 |
Technion Research & Development Foundation Ltd. |
Nucleic acid construct for increasing abiotic stress tolerance in plants
|
WO2012011113A2
(en)
|
2010-07-22 |
2012-01-26 |
Shai Yarkoni |
Regulatory immune cells with enhanced targeted cell death effect
|
US20130130387A1
(en)
|
2010-07-27 |
2013-05-23 |
Technion Research & Development Foundation Limited |
Method for generating induced pluripotent stem cells from keratinocytes derived from plucked hair follicles
|
WO2012014208A2
(en)
|
2010-07-27 |
2012-02-02 |
Yeda Research And Development Co. Ltd. |
Methods and systems for assessing clonality of cell cultures
|
US9144585B2
(en)
|
2010-07-27 |
2015-09-29 |
Technion Research & Development Foundation Limited |
Isolated mesenchymal progenitor cells and extracellular matrix produced thereby
|
WO2012017439A2
(en)
|
2010-08-04 |
2012-02-09 |
Ramot At Tel-Aviv University Ltd. |
Methods of treating autoimmune diseases of the central nervous system (cns) and neurodegenerative diseases
|
WO2012025914A1
(en)
|
2010-08-22 |
2012-03-01 |
Ramot At Tel-Aviv University Ltd. |
Induced pluripotent stem cells derived from human pancreatic beta cells
|
WO2012025925A1
(en)
|
2010-08-24 |
2012-03-01 |
Rappaport Family Institute For Research In The Medical Sciences |
Methods of improving transplantation using sdf-1alpha
|
CA2809384C
(en)
|
2010-08-30 |
2022-07-19 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance
|
WO2012032510A1
(en)
|
2010-09-07 |
2012-03-15 |
Yeda Research And Development Co. Ltd. |
Primers for amplifying dna and methods of selecting same
|
EP2613799A1
(de)
|
2010-09-07 |
2013-07-17 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Readthrough-acetylcholinesterase (ache-r) zur behandlung bzw. prävention von morbus parkinson
|
WO2012032519A2
(en)
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of diagnosing parkinson's disease
|
EP2614141B1
(de)
|
2010-09-07 |
2019-07-31 |
Technion Research & Development Foundation Limited |
Neuartige verfahren und kulturmedien zur kultivierung von pluripotenten stammzellen
|
KR20130105652A
(ko)
|
2010-09-08 |
2013-09-25 |
예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 |
안정하고 장기간의 인그래프트먼트를 위한 면역억제 약물의 조합
|
BR112013005756A2
(pt)
|
2010-09-08 |
2018-12-26 |
Yeda Research And Development Co. Ltd |
use of anti third party central memory t cells for anti-leukemia/lymphoma treatment
|
EP2616539A1
(de)
|
2010-09-15 |
2013-07-24 |
Ramot at Tel-Aviv University Ltd. |
Verfahren zur expansion und redifferenzierung von beta-inselzellen
|
WO2012038956A1
(en)
|
2010-09-20 |
2012-03-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating neurodegenerative diseases
|
EP2627766B1
(de)
|
2010-10-17 |
2016-05-25 |
Yeda Research and Development Co. Ltd. |
Verfahren und zusammensetzungen zur behandlung von insulinassoziierten erkrankungen
|
WO2012052878A1
(en)
|
2010-10-19 |
2012-04-26 |
Vascular Biogenics Ltd. |
Isolated polynucleotides and nucleic acid constructs for directing expression of a gene-of-interest in cells
|
WO2012056452A2
(en)
|
2010-10-27 |
2012-05-03 |
Nanocyte (Israel) Ltd. |
Pharmaceutical compositions and delivery devices comprising stinging cells or capsules
|
US10066024B2
(en)
|
2010-10-28 |
2018-09-04 |
Yeda Research And Development Co. Ltd. |
Methods of generating antibodies to metalloenzymes
|
AR083708A1
(es)
|
2010-11-03 |
2013-03-13 |
Yissum Res Dev Co |
Plantas transgenicas con rendimientos de sacarificacion altos y metodos para generarlas
|
WO2012059925A2
(en)
|
2010-11-04 |
2012-05-10 |
Ben-Gurion University Of The Negev Research And Development Authority |
Acyl-coa: diacylglycerol acyltransferase 1-like gene (ptdgat1) and uses thereof
|
EP3431489B1
(de)
|
2010-11-15 |
2020-12-23 |
Ramot at Tel-Aviv University Ltd. |
Dipeptidanaloga zur behandlung von störungen im zusammenhang mit amyloid-fibrillen-bildung
|
US10117895B2
(en)
|
2010-11-17 |
2018-11-06 |
Ben-Gurion University Of The Negev Research And Development Authority |
T-cell therapy to neurodegenerative diseases
|
JP6139410B2
(ja)
|
2010-12-02 |
2017-05-31 |
テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド |
角膜細胞の作製方法および該角膜細胞を含む細胞集団
|
US20120183960A1
(en)
|
2010-12-07 |
2012-07-19 |
Enterologics, Inc. |
Method for identifying e. coli m-17
|
CA2816495C
(en)
|
2010-12-15 |
2020-10-13 |
Kadimastem Ltd. |
Insulin producing cells derived from pluripotent stem cells
|
AU2011346525B2
(en)
|
2010-12-22 |
2016-04-28 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for improving plant properties
|
SG191768A1
(en)
|
2010-12-28 |
2013-08-30 |
Kamedis Ltd |
Plant extracts for the treatment and prevention of infections
|
US9732333B2
(en)
|
2011-01-20 |
2017-08-15 |
Protalix Ltd. |
Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells
|
WO2012104851A1
(en)
|
2011-01-31 |
2012-08-09 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing disease using overlap extension pcr
|
US20130330349A1
(en)
|
2011-02-23 |
2013-12-12 |
Rappaport Family Institute For Research In The Medical Sciences |
High affinity molecules capable of binding a type a plexin receptor and uses of same
|
US9856492B2
(en)
|
2011-03-02 |
2018-01-02 |
Futuragene Israel Ltd. |
Bacterial resistant transgenic plants having dysfunctional T3SS proteins
|
WO2012117373A1
(en)
|
2011-03-03 |
2012-09-07 |
Ramot At Tel-Aviv University Ltd. |
Genetically modified muscle cells which express neurotrophic factors
|
US9574003B2
(en)
|
2011-03-06 |
2017-02-21 |
Merck Serono S.A. |
Low fucose cell lines and uses thereof
|
US9061006B2
(en)
|
2011-03-08 |
2015-06-23 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for diagnosing and treating phenylketonuria (PKU)
|
WO2012123938A1
(en)
|
2011-03-17 |
2012-09-20 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Quinolone analogs for treating autoimmune diseases
|
US9624291B2
(en)
|
2011-03-17 |
2017-04-18 |
Ramot At Tel-Aviv University Ltd. |
Bi- and monospecific, asymmetric antibodies and methods of generating the same
|
EP3260533B1
(de)
|
2011-03-22 |
2019-09-11 |
Pluristem Ltd. |
Verfahren zur behandlung von strahlungs- oder chemischen verletzungen
|
CN103648517B
(zh)
|
2011-03-24 |
2016-04-20 |
纽瑞姆制药(1991)有限公司 |
神经保护肽
|
WO2012131680A2
(en)
|
2011-03-28 |
2012-10-04 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating inflammation
|
WO2012137202A1
(en)
|
2011-04-05 |
2012-10-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Composition comprising an iron indicator attached to a microparticle and uses of same for quantifying non-transferrin bound iron (ntbi) and cellular labile iron (lci)
|
ES2627154T3
(es)
|
2011-04-06 |
2017-07-26 |
Ramot At Tel-Aviv University Ltd. |
Métodos de seguimiento y análisis de perfiles de actividad metabólica, usos diagnósticos y terapéuticos de los mismos
|
WO2012142164A1
(en)
|
2011-04-12 |
2012-10-18 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Human monoclonal antibodies that bind insulin-like growth factor (igf) i and ii
|
IL254464B2
(en)
|
2011-04-15 |
2023-12-01 |
Pluri Biotech Ltd |
Methods and systems for harvesting cells
|
WO2012150598A2
(en)
|
2011-05-03 |
2012-11-08 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
|
EP2704793B1
(de)
|
2011-05-04 |
2019-07-17 |
Ramot at Tel Aviv University, Ltd. |
Regulierung einer molekularen amyloid-beta -zusammensetzung zur behandlung von morbus alzheimer
|
WO2012153333A1
(en)
|
2011-05-09 |
2012-11-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Regeneration and repair of mesenchymal tissue using amelogenin
|
WO2012153336A2
(en)
|
2011-05-12 |
2012-11-15 |
Rakuto Bio Technologies Ltd. |
Methods and device for lightening skin complexion
|
WO2012156976A1
(en)
|
2011-05-16 |
2012-11-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of producing artemisinin in non-host plants and vectors for use in same
|
WO2012160526A2
(en)
|
2011-05-23 |
2012-11-29 |
Ofir Menashe |
Formulations of microorganism comprising particles and uses of same
|
EP2715350B1
(de)
|
2011-05-23 |
2017-09-27 |
Yeda Research and Development Co. Ltd. |
Verwendung einer akt-phosphorylierung als biomarker zur prognose neurodegenerativer erkrankungen und zu ihrer behandlung
|
CA2837412C
(en)
|
2011-05-31 |
2020-04-28 |
Hutchison Biofilm Medical Solutions Limited |
Dispersion and detachment of cell aggregates
|
US20140113376A1
(en)
|
2011-06-01 |
2014-04-24 |
Rotem Sorek |
Compositions and methods for downregulating prokaryotic genes
|
US10166295B2
(en)
|
2011-06-02 |
2019-01-01 |
Opko Biologics Ltd. |
Pegylated OXM variants
|
ES2670596T3
(es)
|
2011-06-14 |
2018-05-31 |
Yeda Research And Development Co. Ltd. |
Terapia de combinación para prevenir la formación del DCIS y la progresión hasta cáncer de mama
|
RU2014101662A
(ru)
|
2011-06-23 |
2015-07-27 |
Каиима Био Агритех Лтд. |
Мягкая пшеница, растения или их части с частично или полностью мультиплицированным геномом, гибриды и их продукты, а также способы их получения и применения
|
BR112014001348A2
(pt)
|
2011-07-20 |
2017-07-18 |
Kaiima Bio Agritech Ltd |
plantas de milho parcial ou totalmente multiplicado e usos respectivos
|
EP2550982A1
(de)
|
2011-07-27 |
2013-01-30 |
Technion Research & Development Foundation Ltd. |
Vorrichtungen für chirurgische Anwendungen
|
BR112014002737B1
(pt)
|
2011-08-04 |
2022-08-02 |
Yeda Research And Development Co. Ltd. |
Mir-135
|
JP6063613B2
(ja)
|
2011-08-09 |
2017-01-18 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
ベータ細胞の分化およびインスリン産生を促進するためのmiR−7のダウンレギュレーション
|
MX2014001777A
(es)
|
2011-08-14 |
2014-08-21 |
Kaiima Bio Agritech Ltd |
Plantas de trigo durum que tienen un genoma parcial completamente multiplicado y sus usos.
|
EP2753367A4
(de)
|
2011-09-07 |
2015-10-14 |
Yeda Res & Dev |
Olfaktorische signatur und odorierungsmischung damit
|
SG11201400513PA
(en)
|
2011-09-08 |
2014-06-27 |
Yeda Res & Dev |
Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatment
|
US20140248293A1
(en)
|
2011-09-08 |
2014-09-04 |
Yeda Research And Development Co., Ltd |
Novel risk biomarkers for lung cancer
|
WO2013040049A1
(en)
|
2011-09-13 |
2013-03-21 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
UA116089C2
(uk)
|
2011-09-13 |
2018-02-12 |
Монсанто Текнолоджи Ллс |
Спосіб та композиція для боротьби з бур'янами (варіанти)
|
US10806146B2
(en)
|
2011-09-13 |
2020-10-20 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10829828B2
(en)
|
2011-09-13 |
2020-11-10 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
MX362810B
(es)
|
2011-09-13 |
2019-02-13 |
Monsanto Technology Llc |
Metodos y composiciones para controlar malezas.
|
WO2013040116A1
(en)
|
2011-09-13 |
2013-03-21 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10760086B2
(en)
|
2011-09-13 |
2020-09-01 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
WO2013054320A1
(en)
|
2011-10-11 |
2013-04-18 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam)
|
AU2012325604B2
(en)
|
2011-10-21 |
2017-08-03 |
Augurex Life Sciences Corp. |
Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis
|
US9145559B2
(en)
|
2011-10-27 |
2015-09-29 |
Yeda Research And Development Co. Ltd. |
Methods of treating cancer
|
CN103917647B
(zh)
|
2011-11-03 |
2020-07-10 |
夸克制药公司 |
用于神经保护的方法和组合物
|
WO2013070821A1
(en)
|
2011-11-08 |
2013-05-16 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the nervous system
|
WO2013076729A1
(en)
|
2011-11-23 |
2013-05-30 |
Danziger Dan Flower Farm |
Otomeria plants
|
WO2013076730A1
(en)
|
2011-11-27 |
2013-05-30 |
Yeda Research And Development Co. Ltd. |
Methods of regulating angiogenesis and compositions capable of same
|
CN104105493A
(zh)
|
2011-12-08 |
2014-10-15 |
耶达研究及发展有限公司 |
哺乳动物胎儿肺细胞以及其治疗用途
|
WO2013093921A1
(en)
|
2011-12-20 |
2013-06-27 |
Collplant Ltd. |
Collagen coated synthetic polymer fibers
|
EP2794107B1
(de)
|
2011-12-22 |
2021-08-11 |
Life Technologies Corporation |
Sequenzielle lateralfluss-kapillarvorrichtung zur analytbestimmung
|
RU2657758C2
(ru)
|
2011-12-22 |
2018-06-15 |
Иеда Рисеч Энд Девелопмент Ко. Лтд. |
Комбинированная терапия для стабильного и долговременного приживления трансплантата
|
CN104270939A
(zh)
|
2011-12-28 |
2015-01-07 |
凯伊玛生物农业科技有限公司 |
具有部分加倍或完全加倍的基因组的栽培高粱植物及其应用
|
US20150216998A1
(en)
|
2012-01-01 |
2015-08-06 |
Ramot At Tel-Aviv University Ltd. |
Endo180-targeted particles for selective delivery of therapeutic and diagnostic agents
|
WO2013114363A2
(en)
|
2012-01-30 |
2013-08-08 |
Yeda Research And Development Co.Ltd. |
Antimicrobial agents
|
WO2013114374A1
(en)
|
2012-02-01 |
2013-08-08 |
Protalix Ltd. |
Dnase i polypeptides, polynucleotides encoding same, methods of producing dnase i and uses thereof in therapy
|
US10184131B2
(en)
|
2012-02-06 |
2019-01-22 |
A.B. Seeds Ltd. |
Isolated polynucleotides expressing or modulating microRNAs or targets of same, transgenic plants comprising same and uses thereof
|
AU2013219945B2
(en)
|
2012-02-13 |
2017-12-07 |
Gamida-Cell Ltd. |
Culturing of mesenchymal stem cells
|
AU2013219935B2
(en)
|
2012-02-14 |
2016-02-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
WO2013121405A1
(en)
|
2012-02-19 |
2013-08-22 |
Protalix Ltd. |
Oral unit dosage forms and uses of same for the treatment of gaucher disease
|
JP6329911B2
(ja)
|
2012-02-22 |
2018-05-23 |
ブレインステム バイオテック リミテッド |
星状膠細胞作製のためのミクロrna
|
EP2844745A2
(de)
|
2012-02-22 |
2015-03-11 |
Brainstem Biotec Ltd. |
Erzeugung von neuralen stammzellen und motorneuronen
|
US20150101074A1
(en)
|
2012-03-01 |
2015-04-09 |
The State of Israel, Ministry of Agriculture & Rural Development, Agriculture Research |
Male sterile garlic plants, hybrid offspring of same and methods of generating and using same
|
ES2691931T3
(es)
|
2012-03-07 |
2018-11-29 |
Yeda Research And Development Co. Ltd. |
Composiciones para inhibición de quiescina sulfhidrilo oxidasa (QSOX1) y usos de las mismas
|
US9334308B2
(en)
|
2012-03-22 |
2016-05-10 |
Ramot At Tel-Aviv University Ltd. |
PLIF multimeric peptides and uses thereof
|
CA2868238A1
(en)
|
2012-04-18 |
2013-10-24 |
Ramot At Tel Aviv University Ltd. |
Lipidated glycosaminoglycan particles for the delivery of nucleic acids
|
WO2013157002A1
(en)
|
2012-04-19 |
2013-10-24 |
Prolor Biotech Inc. |
Long-acting oxyntomodulin variants and methods of producing same
|
EP2841084B1
(de)
|
2012-04-24 |
2018-05-30 |
Biokine Therapeutics Ltd. |
Cxcr4 antagonist peptid zur verwendung in der behandlung von lungenkrebs
|
EP2846819B1
(de)
|
2012-05-09 |
2017-05-03 |
Yeda Research and Development Co. Ltd. |
Varianten der tace pro-domäne als tnf-a-hemmer und deren medizinische verwendung
|
US8865158B2
(en)
|
2012-05-22 |
2014-10-21 |
Ramot At Tel-Aviv University Ltd. |
Bacteriophages for reducing toxicity of bacteria
|
WO2013175480A1
(en)
|
2012-05-24 |
2013-11-28 |
A.B. Seeds Ltd. |
Compositions and methods for silencing gene expression
|
JP5868549B2
(ja)
|
2012-05-24 |
2016-02-24 |
マウントゲイト グループ リミテッド |
狂犬病感染の予防および治療に関する組成物および方法
|
EP2855507B1
(de)
|
2012-06-03 |
2018-01-03 |
Ben-Gurion University of The Negev Research and Development Authority |
Funktionalisierte titanbindende peptide und damit beschichtete implantate
|
JP6290193B2
(ja)
|
2012-06-04 |
2018-03-07 |
オプコ バイオロジクス リミテッド |
ペグ化oxm変異体
|
WO2014006621A1
(en)
|
2012-07-03 |
2014-01-09 |
Nanospun Technologies Ltd. |
Methods and devices for adsorption and biodegradation of petroleum
|
US9567569B2
(en)
|
2012-07-23 |
2017-02-14 |
Gamida Cell Ltd. |
Methods of culturing and expanding mesenchymal stem cells
|
US9175266B2
(en)
|
2012-07-23 |
2015-11-03 |
Gamida Cell Ltd. |
Enhancement of natural killer (NK) cell proliferation and activity
|
EP2880155B1
(de)
|
2012-07-29 |
2019-04-17 |
Yeda Research and Development Co., Ltd. |
Verwendung des reduktiven glycinpfades zur erzeugung formatotropher und autotropher mikroorganismen
|
JP6340366B2
(ja)
|
2012-07-31 |
2018-06-06 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
運動ニューロン疾患を診断および処置する方法
|
CA2877223C
(en)
|
2012-08-06 |
2019-08-27 |
Brainstorm Cell Therapeutics Ltd. |
Methods of generating mesenchymal stem cells which secrete neurotrophic factors
|
WO2014033723A1
(en)
|
2012-09-03 |
2014-03-06 |
A.B. Seeds Ltd. |
Method of improving abiotic stress tolerance of plants and plants generated thereby
|
EP2895197B1
(de)
|
2012-09-12 |
2020-02-26 |
Ramot at Tel-Aviv University Ltd. |
Immunpartikel, verfahren zu deren herstellung, und deren verwendung
|
WO2014057490A1
(en)
|
2012-10-09 |
2014-04-17 |
Ramot At Tel-Aviv University Ltd. |
Methods and kits for predicting prognosis of cancer using soluble mortalin in blood
|
EP2908864B1
(de)
|
2012-10-22 |
2019-12-11 |
Sabag-Rfa Ltd. |
Phosphatverbindungen zur abgabe von therapeutika in lebende zellen und zellkerne
|
EP2912062A1
(de)
|
2012-10-24 |
2015-09-02 |
Yeda Research and Development Co. Ltd. |
Kombinationen von auf den epidermalen wachstumsfaktorrezeptor gerichteten antikörpern zur krebsbehandlung
|
EP2912181B1
(de)
|
2012-10-29 |
2017-11-29 |
Yeda Research and Development Co., Ltd. |
Aptamere, multimere aptamere und verwendungen davon
|
CN112661863A
(zh)
|
2012-11-20 |
2021-04-16 |
奥普科生物制品有限公司 |
通过连接至促性腺激素羧基端肽来增加多肽的流体动力学体积的方法
|
WO2015079413A2
(en)
|
2013-11-28 |
2015-06-04 |
Yeda Research And Development Co. Ltd. |
Synaptojanin-2 inhibitors and uses thereof
|
AU2013350721A1
(en)
|
2012-11-29 |
2015-01-29 |
Yeda Research And Development Co. Ltd. |
Methods of preventing tumor metastasis, treating and prognosing cancer and identifying agents which are putative metastasis inhibitors
|
US10683505B2
(en)
|
2013-01-01 |
2020-06-16 |
Monsanto Technology Llc |
Methods of introducing dsRNA to plant seeds for modulating gene expression
|
CA2896762A1
(en)
|
2013-01-01 |
2014-07-10 |
A.B. Seeds Ltd. |
Methods of introducing dsrna to plant seeds for modulating gene expression
|
WO2014108850A2
(en)
|
2013-01-09 |
2014-07-17 |
Yeda Research And Development Co. Ltd. |
High throughput transcriptome analysis
|
WO2014108854A1
(en)
|
2013-01-09 |
2014-07-17 |
Fusimab Ltd. |
Monospecific anti-hgf and anti-ang2 antibodies and bispecific anti-hgf/anti-ang2 antibodies
|
JP6411372B2
(ja)
|
2013-01-17 |
2018-10-24 |
ノベルラスディクス リミテッド |
患者特有のドライバー変異を特定するための方法およびシステム
|
WO2014118785A1
(en)
|
2013-02-04 |
2014-08-07 |
Ramot At Tel-Aviv University Ltd. |
Generation of cytotoxic tumor specific cell lines and uses thereof
|
CN105121460A
(zh)
|
2013-03-06 |
2015-12-02 |
波塔力克斯有限公司 |
表达TNFα多肽抑制的植物细胞在治疗中的用途
|
AU2014224171B2
(en)
|
2013-03-06 |
2018-02-01 |
Protalix Ltd. |
Tnf alpha inhibitor polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same
|
US10612019B2
(en)
|
2013-03-13 |
2020-04-07 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
MX364458B
(es)
|
2013-03-13 |
2019-04-26 |
Monsanto Technology Llc |
Métodos y composiciones para el control de malezas.
|
US10568328B2
(en)
|
2013-03-15 |
2020-02-25 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
ES2883580T3
(es)
|
2013-03-21 |
2021-12-09 |
Collplant Ltd |
Composiciones que comprenden colágeno y PRP para la regeneración de tejidos y su método de producción
|
WO2014155376A1
(en)
|
2013-03-24 |
2014-10-02 |
Biokine Therapeutics Ltd. |
Methods of treating myeloid leukemia
|
BR112015026702A2
(pt)
|
2013-04-21 |
2018-02-06 |
Yeda Res And Developmente Co Ltd |
métodos de extermínio de células senescentes
|
ES2831424T3
(es)
|
2013-04-23 |
2021-06-08 |
Yeda Res & Dev |
Células madre pluripotentes naif aisladas y métodos para generarlas
|
EP2989119B1
(de)
|
2013-04-25 |
2018-03-21 |
Yeda Research and Development Co., Ltd. |
Verwendung von inhibierenden peptiden zur behandlung von entzündlichen erkrankungen
|
US20160115231A1
(en)
|
2013-05-21 |
2016-04-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Treatment of mast cell related pathologies
|
CN105407867A
(zh)
|
2013-05-27 |
2016-03-16 |
洛东生物科技有限公司 |
含酶系统的美容组合物
|
ES2938044T3
(es)
|
2013-06-24 |
2023-04-04 |
Univ Ramot |
Estructura a base de epiplón y sistema de suministro
|
UA122662C2
(uk)
|
2013-07-19 |
2020-12-28 |
Монсанто Текнолоджі Ллс |
Композиція та спосіб боротьби з leptinotarsa
|
US9850496B2
(en)
|
2013-07-19 |
2017-12-26 |
Monsanto Technology Llc |
Compositions and methods for controlling Leptinotarsa
|
WO2015015489A1
(en)
|
2013-07-30 |
2015-02-05 |
Biolinerx Ltd. |
Antibody for treating diabetes and autoimmune diseases
|
US9938316B2
(en)
|
2013-08-29 |
2018-04-10 |
Yeda Research And Development Co. Ltd. |
Selective inhibitors of α2 isoform of Na,K-ATPase and use thereof for reduction of intra-ocular pressure and as cardiotonic agents
|
WO2015033343A1
(en)
|
2013-09-03 |
2015-03-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compositions and methods for expressing recombinant polypeptides
|
IL228284A
(en)
|
2013-09-03 |
2016-12-29 |
Technion Res & Dev Foundation |
Implants from cellular scaffolding and blood vessel stalk
|
WO2015033344A1
(en)
|
2013-09-05 |
2015-03-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and kits for inhibiting pathogenicity of group a streptococcus (gas) or group g streptococcus (ggs)
|
WO2015037009A1
(en)
|
2013-09-16 |
2015-03-19 |
Plexicure Ltd. |
Isolated proteins capable of binding plexin-a4 and methods of producing and using same
|
EP3046929B1
(de)
|
2013-09-17 |
2019-01-16 |
Yeda Research and Development Co., Ltd. |
Aus erk gewonnene peptide und verwendungen davon
|
WO2015049677A1
(en)
|
2013-10-01 |
2015-04-09 |
Kadimastem Ltd. |
Directed differentiation of astrocytes from human pluripotent stem cells for use in drug screening and the treatment of amyotrophic lateral sclerosis (als)
|
EP3763733A1
(de)
|
2013-10-21 |
2021-01-13 |
OPKO Biologics Ltd. |
Polypeptide mit langzeitwirkung sowie verfahren zur herstellung und verabreichung davon
|
US20150158926A1
(en)
|
2013-10-21 |
2015-06-11 |
Opko Biologics, Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US10767156B2
(en)
|
2013-10-24 |
2020-09-08 |
Yeda Research And Development Co., Ltd. |
Polynucleotides encoding BREX system polypeptides and methods of using same
|
ES2811804T3
(es)
|
2013-10-31 |
2021-03-15 |
Biokine Therapeutics Ltd |
Un inhibidor peptídico de CXCR4 para su uso en el tratamiento de la leucemia mieloide aguda con una mutación de FLT3
|
AR098295A1
(es)
|
2013-11-04 |
2016-05-26 |
Monsanto Technology Llc |
Composiciones y métodos para controlar infestaciones de plagas y parásitos de los artrópodos
|
EP3074391B1
(de)
|
2013-11-28 |
2019-07-31 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Rna-polymerase-hemmer und verwendungen davon
|
UA119253C2
(uk)
|
2013-12-10 |
2019-05-27 |
Біолоджикс, Інк. |
Спосіб боротьби із вірусом у кліща varroa та у бджіл
|
EP3080243B1
(de)
|
2013-12-10 |
2018-09-05 |
Yeda Research and Development Co., Ltd. |
Verwendung von enzymen zur katalysierung einer pyruvatsynthese aus formiat und acetyl-coa sowie bakterien zur expression davon
|
US10334848B2
(en)
|
2014-01-15 |
2019-07-02 |
Monsanto Technology Llc |
Methods and compositions for weed control using EPSPS polynucleotides
|
WO2015114633A1
(en)
|
2014-01-30 |
2015-08-06 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. |
Actin binding peptides and compositions comprising same for inhibiting angiogenes is and treating medical conditions associated with same
|
JP2017506259A
(ja)
|
2014-02-03 |
2017-03-02 |
イッスム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム・リミテッドYissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
幹細胞を枯渇させるためのカゼインキナーゼi阻害剤の使用
|
CN106715695B
(zh)
|
2014-02-05 |
2020-07-31 |
耶达研究及发展有限公司 |
用于治疗和诊断的微rna和包含所述微rna的组合物
|
WO2015118538A1
(en)
|
2014-02-06 |
2015-08-13 |
Yeda Research And Development Co. Ltd. |
Anti cd84 antibodies, compositions comprising same and uses thereof
|
US20170101633A1
(en)
|
2014-02-10 |
2017-04-13 |
Protalix Ltd. |
Method of maintaining disease stability in a subject having gaucher's disease
|
WO2015121859A1
(en)
|
2014-02-11 |
2015-08-20 |
Brainstorm Cell Therapeutics Ltd. |
Method of qualifying cells
|
EP3114483A1
(de)
|
2014-03-03 |
2017-01-11 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Verfahren und vorrichtung für den nachweis von pseudomonas aeruginosa
|
EP2923709A1
(de)
|
2014-03-28 |
2015-09-30 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Mehrstufiger Mehrkomponenten-Malariaimpfstoff
|
WO2015153339A2
(en)
|
2014-04-01 |
2015-10-08 |
Monsanto Technology Llc |
Compositions and methods for controlling insect pests
|
EP3129075A4
(de)
|
2014-04-10 |
2017-12-06 |
Bonus Therapeutics Ltd. |
Knochenreparaturzusammensetzungen
|
WO2015159293A2
(en)
|
2014-04-14 |
2015-10-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
A method and kit for determining the tissue or cell origin of dna
|
WO2015159295A1
(en)
|
2014-04-17 |
2015-10-22 |
Yeda Research And Development Co. Ltd. |
Methods and kits for analyzing dna binding moieties attached to dna
|
EP3137502B1
(de)
|
2014-04-27 |
2020-07-29 |
FameWave Ltd. |
Humanisierte antikörper gegen ceacam1
|
US11427647B2
(en)
|
2014-04-27 |
2022-08-30 |
Famewave Ltd. |
Polynucleotides encoding humanized antibodies against CEACAM1
|
CN106460048B
(zh)
|
2014-04-28 |
2021-01-05 |
耶达研究及发展有限公司 |
针对试剂的微生物组应答
|
WO2015170322A2
(en)
|
2014-05-04 |
2015-11-12 |
Forrest Innovations Ltd. |
Compositions and methods of using same for increasing resistance of infected mosquitoes
|
EP3145947A2
(de)
|
2014-05-22 |
2017-03-29 |
Yeda Research and Development Co., Ltd. |
Rekombinante mikroorganismen zur kohlenstofffixierung
|
US20170253881A1
(en)
|
2014-06-02 |
2017-09-07 |
Technion Research & Development Foundation Limited |
Compositions and methods of selectively inhibiting irp1 and treating inflammation
|
WO2015186128A1
(en)
|
2014-06-02 |
2015-12-10 |
Kadimastem Ltd. |
Methods of inducing myelination and maturation of oligodendrocytes
|
AU2015280252A1
(en)
|
2014-06-23 |
2017-01-12 |
Monsanto Technology Llc |
Compositions and methods for regulating gene expression via RNA interference
|
WO2015198320A1
(en)
|
2014-06-24 |
2015-12-30 |
Insight Biopharmaceuticals Ltd. |
Methods of purifying antibodies
|
WO2015200539A1
(en)
|
2014-06-25 |
2015-12-30 |
Monsanto Technology Llc |
Methods and compositions for delivering nucleic acids to plant cells and regulating gene expression
|
SG11201610630RA
(en)
|
2014-06-25 |
2017-01-27 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Identification of cancer stem cell markers and use of same for diagnosis and treatment
|
WO2015198326A1
(en)
|
2014-06-26 |
2015-12-30 |
Ramot At Tel-Aviv University Ltd. |
Liposomal formulations for delivery of nucleic acids
|
WO2016005985A2
(en)
|
2014-07-09 |
2016-01-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method for reprogramming cells
|
WO2016009436A1
(en)
|
2014-07-15 |
2016-01-21 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Isolated polypeptides of cd44 and uses thereof
|
CN106715719B
(zh)
|
2014-07-21 |
2022-08-02 |
福尔生物治疗有限公司 |
用于确定患者特定突变的药物反应的方法
|
CN107076727B
(zh)
|
2014-07-21 |
2019-11-01 |
诺威尔卢斯德克有限公司 |
用于确定患者特定突变的致癌指数的方法和系统
|
CN106604993A
(zh)
|
2014-07-29 |
2017-04-26 |
孟山都技术公司 |
用于控制昆虫害虫的组合物和方法
|
JP2017525351A
(ja)
|
2014-07-30 |
2017-09-07 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
多能性幹細胞の培養用培地
|
EP3699930B1
(de)
|
2014-08-14 |
2024-02-07 |
MeMed Diagnostics Ltd. |
Rechnerische analyse biologischer daten mit verteiler und hyperebene
|
WO2016030899A1
(en)
|
2014-08-28 |
2016-03-03 |
Yeda Research And Development Co. Ltd. |
Methods of treating amyotrophic lateral scleroses
|
US10526416B2
(en)
|
2014-09-08 |
2020-01-07 |
Yeda Research And Development Co. Ltd. |
Anti-HER3 antibodies and uses of same
|
EP3191523B1
(de)
|
2014-09-08 |
2019-08-07 |
Yeda Research and Development Co., Ltd. |
Zusammensetzungen und verfahren zur behandlung von krebs mit resistenz gegenüber einem tyrosinkinasehemmer (tki)
|
EP2992895A1
(de)
|
2014-09-08 |
2016-03-09 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Mehrstufiger Dreikomponenten-Malariaimpfstoff
|
IL234638A0
(en)
|
2014-09-14 |
2014-12-02 |
Yeda Res & Dev |
NMDA receptor antagonists for the treatment of Gaucher disease
|
US10174320B2
(en)
|
2014-09-21 |
2019-01-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Downregulating miR-132 for the treatment of lipid related disorders
|
JP6767374B2
(ja)
|
2014-10-20 |
2020-10-14 |
ジェン−プローブ・インコーポレーテッド |
赤血球溶解溶液
|
EP3217785B1
(de)
|
2014-11-13 |
2023-10-25 |
Enzootic Holdings Ltd. |
Funktionelle geschlechtsumkehrung von zehnfusskrebsweibchen
|
JP2017533723A
(ja)
|
2014-11-17 |
2017-11-16 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
マイクロバイオーム解析方法
|
US20180042994A1
(en)
|
2014-11-17 |
2018-02-15 |
Yeda Research And Development Co. Ltd. |
Methods of treating diseases related to mitochondrial function
|
BR112017010555A2
(pt)
|
2014-11-20 |
2018-02-27 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
composições e métodos para produção de polipeptídeos com padrão de glicosilação modificado em células vegetais
|
CN107208070B
(zh)
|
2014-11-26 |
2021-09-07 |
技术创新动力基金(以色列)有限合伙公司 |
细菌基因的靶向消除
|
JP2017535296A
(ja)
|
2014-11-27 |
2017-11-30 |
ダンツィガー イノベイションズ リミテッドDanziger Innovations Ltd. |
ゲノム編集のための核酸構築物
|
WO2016092555A2
(en)
|
2014-12-11 |
2016-06-16 |
Yeda Research And Development Co. Ltd. |
Isolated phosphotriesterase polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
WO2016103269A1
(en)
|
2014-12-23 |
2016-06-30 |
Ramot At Tel-Aviv University Ltd. |
Populations of neural progenitor cells and methods of producing and using same
|
EP3916085A1
(de)
|
2014-12-30 |
2021-12-01 |
Cell Cure Neurosciences Ltd. |
Beurteilung von netzhautpigmentepithelzellpopulationen
|
AU2015373111B2
(en)
|
2014-12-30 |
2021-06-24 |
Cell Cure Neurosciences Ltd. |
Methods of treating retinal diseases
|
KR20170115514A
(ko)
|
2014-12-30 |
2017-10-17 |
셀 큐어 뉴로사이언시스 리미티드 |
Rpe 세포 집단 및 이를 생성하는 방법
|
WO2016108244A1
(en)
|
2015-01-04 |
2016-07-07 |
Protalix Ltd. |
Modified dnase and uses thereof
|
WO2016116935A1
(en)
|
2015-01-21 |
2016-07-28 |
Yeda Research And Development Co. Ltd. |
Use of rasa2 as a prognostic and therapeutic marker for melanoma
|
BR112017015705A2
(pt)
|
2015-01-22 |
2018-03-20 |
Monsanto Technology Llc |
composições e métodos para controle de leptinotarsa
|
US20180345047A1
(en)
|
2015-02-26 |
2018-12-06 |
Yeda Research And Development Co. Ltd. |
Method of promoting hair growth
|
WO2016142948A1
(en)
|
2015-03-11 |
2016-09-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Decoy oligonucleotides for the treatment of diseases
|
IL237852A0
(en)
|
2015-03-19 |
2016-03-24 |
Yeda Res & Dev |
Antibodies against amphigoline, medical preparations containing them and their use
|
JP2018518152A
(ja)
|
2015-03-27 |
2018-07-12 |
ユニバーシティ オブ サザン カリフォルニア |
充実性腫瘍を処置するためのlhrに指向されたcar t細胞治療
|
EP4218771A1
(de)
|
2015-03-27 |
2023-08-02 |
Yeda Research and Development Co. Ltd |
Verfahren zur behandlung von motoneuronenerkrankungen
|
EP3277308A1
(de)
|
2015-03-31 |
2018-02-07 |
Yeda Research and Development Co., Ltd. |
Glutamatoxaloacetattransaminase 1 (got1), zubereitungen und verfahren zur erzeugung und verwendungen davon
|
EP3277260B1
(de)
|
2015-04-01 |
2021-05-12 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Pflanzenextrakte aus erodium crassifolium l'her und verwendungen davon
|
CA2981732C
(en)
|
2015-04-07 |
2024-03-12 |
Boris Khalfin |
Compositions for treating and/or preventing cell or tissue necrosis specifically targeting cathepsin c and/or cela1 and/or cela3a and/or structurally related enzymes thereto
|
EP3081575A1
(de)
|
2015-04-12 |
2016-10-19 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Anti-plasmodium-parasiten-antikörper
|
CA2986202C
(en)
|
2015-04-27 |
2023-08-22 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Egr1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions
|
US10674732B2
(en)
|
2015-04-29 |
2020-06-09 |
The State Of Israel, Ministry Of Agriculture & Rural Development Agricultural Research Organization |
Anti-phytopathogenic compositions
|
WO2016174652A1
(en)
|
2015-04-30 |
2016-11-03 |
Technion Research & Development Foundation Limited |
Chimeric antigen receptors and methods of their use
|
EP3292219B9
(de)
|
2015-05-04 |
2022-05-18 |
Ramot at Tel-Aviv University Ltd. |
Verfahren und kits zur fragmentierung von dna
|
US20180161300A1
(en)
|
2015-05-11 |
2018-06-14 |
Yeda Research And Development Co., Ltd. |
Citrin inhibitors for the treatment of cancer
|
EP3298141A4
(de)
|
2015-05-17 |
2019-01-09 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Zusammensetzungen und verfahren zur behandlung von krebs
|
WO2016185457A1
(en)
|
2015-05-19 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Methods of promoting lymphangiogenesis
|
WO2016185481A2
(en)
|
2015-05-20 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Method of targeting senescent cells
|
US20180140648A1
(en)
|
2015-05-21 |
2018-05-24 |
Yeda Research And Development Co. Ltd. |
Bacterial populations for promoting health
|
EP3302571B1
(de)
|
2015-05-29 |
2020-11-18 |
OPKO Biologics Ltd. |
Pegylierte oxyntomodulin-varianten
|
WO2016196738A1
(en)
|
2015-06-02 |
2016-12-08 |
Monsanto Technology Llc |
Compositions and methods for delivery of a polynucleotide into a plant
|
WO2016196782A1
(en)
|
2015-06-03 |
2016-12-08 |
Monsanto Technology Llc |
Methods and compositions for introducing nucleic acids into plants
|
EP3302559B1
(de)
|
2015-06-04 |
2022-01-12 |
University of Southern California |
Auf lym-1 und lym-2 abgerichtete car-zellen-immuntherapie
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
WO2016203476A1
(en)
|
2015-06-18 |
2016-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and compositions for diagnosing and treating urothelial cancer
|
ES2917884T3
(es)
|
2015-06-18 |
2022-07-12 |
Yeda Res & Dev |
Protocolos de acondicionamiento y uso de los mismos para la regeneración de tejidos
|
EP3988113A1
(de)
|
2015-06-19 |
2022-04-27 |
OPKO Biologics Ltd. |
Gerinnungsfaktoren mit langzeitwirkung und verfahren zur herstellung davon
|
CA2986705A1
(en)
|
2015-07-16 |
2017-01-19 |
Biokine Therapeutics Ltd. |
A cxcr4 inhibitor and a pdi antagonist for use in treating cancer
|
PL3322424T3
(pl)
|
2015-07-16 |
2024-03-04 |
Yeda Research And Development Co., Ltd. |
Zastosowanie centralnych limfocytów t pamięci przeciwko stronie trzeciej
|
EP3325494B1
(de)
|
2015-07-19 |
2020-12-30 |
Yeda Research and Development Co., Ltd. |
Selektive inhibitoren der alpha2-haltigen isoformen der na, k-atpase und deren verwendung zur reduzierung des augeninnendruckes
|
BR112018001310A2
(pt)
|
2015-07-22 |
2018-09-11 |
Phytopharma Int Ltd |
composições ingeríveis por abelha, métodos de uso das mesmas para a produção de mel e mel produzido por estas
|
ES2865024T3
(es)
|
2015-07-29 |
2021-10-14 |
Hadasit Med Res Service |
Producción a gran escala de células de epitelio pigmentario retiniano
|
EP3331546B1
(de)
|
2015-08-03 |
2023-10-04 |
Biokine Therapeutics Ltd. |
Cxcr4-antagonist zur behandlung von krebs
|
US20180237774A1
(en)
|
2015-08-04 |
2018-08-23 |
Yeda Research And Development Co. Ltd. |
Methods of screening for riboswitches and attenuators
|
DK3331994T3
(da)
|
2015-08-05 |
2022-11-21 |
Cell Cure Neurosciences Ltd |
Fremstilling af retinale pigmentepitelceller
|
EP3331995A1
(de)
|
2015-08-05 |
2018-06-13 |
Cell Cure Neurosciences Ltd. |
Zubereitung von fotorezeptoren zur behandlung von netzhauterkrankungen
|
EP3334449B1
(de)
|
2015-08-10 |
2021-09-29 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Verfahren und pharmazeutische zusammensetzungen zur verbesserung der wundheilung mithilfe von cd24
|
WO2017025967A1
(en)
|
2015-08-13 |
2017-02-16 |
Forrest Innovations Ltd. |
Formulations and compositions for delivery of nucleic acids to plant cells
|
WO2017033188A1
(en)
|
2015-08-24 |
2017-03-02 |
Yeda Research And Development Co. Ltd. |
Algal oil and biofuel and methods of producing same
|
US10765706B2
(en)
|
2015-09-03 |
2020-09-08 |
University Of South Florida |
Method of stem cell delivery into the brain during chronic disease using blood brain barrier permeabilizers
|
WO2017042816A1
(en)
|
2015-09-10 |
2017-03-16 |
Yeda Research And Development Co. Ltd. |
Ablation of perforin positive dendritic cells in cancer treatment
|
EP3365376A1
(de)
|
2015-10-25 |
2018-08-29 |
Yeda Research and Development Co., Ltd. |
Auf quiescin-sulfhydryl-oxidase (qsox1) abzielende antikörper und verwendungen davon
|
WO2017072763A1
(en)
|
2015-10-26 |
2017-05-04 |
Cell Cure Neurosciences Ltd. |
Preparation of retinal pigment epithelium cells
|
KR20180102053A
(ko)
|
2015-10-27 |
2018-09-14 |
제이 파마 인코포레이티드 |
칸나비다이올 및 제2 치료제를 포함하는, 암을 치료하기 위한 조성물
|
IL242380A0
(en)
|
2015-10-29 |
2016-02-01 |
Yeda Res & Dev |
A method for inducing the division of cardiomyocytes and treating heart diseases
|
US20180303974A1
(en)
|
2015-11-03 |
2018-10-25 |
Ariel-University Research And Development Company Ltd. |
Compositions for regeneration and repair of neural tissue
|
WO2017081689A1
(en)
|
2015-11-11 |
2017-05-18 |
Ramot At Tel-Aviv University Ltd. |
Methods of detecting 5-hydroxymethylcytosine and diagnosing of cancer
|
BR112018010946A2
(pt)
|
2015-11-30 |
2018-12-04 |
Kadimastem Ltd |
método para enriquecimento de células endócrinas pancreáticas, população enriquecida de células endócrinas pancreáticas, método de tratamento de diabetes e método de preparação de células beta de produção de insulina
|
EP3176183A1
(de)
|
2015-12-02 |
2017-06-07 |
Yeda Research and Development Co. Ltd |
Zusammensetzungen und verfahren zur behandlung von krebs ohne resistenz gegen einen tyrosinkinasehemmer (tki)
|
ES2924732T3
(es)
|
2015-12-16 |
2022-10-10 |
Univ Ramot |
Partículas que comprenden epiplón descelularizado
|
US10561706B2
(en)
|
2015-12-28 |
2020-02-18 |
B. G. Negev Technologies And Applications |
Isolated polypeptide and compositions comprising same
|
CN108697907A
(zh)
|
2016-01-06 |
2018-10-23 |
耶达研究及发展有限公司 |
用于治疗恶性疾病、自身免疫疾病和炎性疾病的组合物和方法
|
US20190178888A1
(en)
|
2016-01-11 |
2019-06-13 |
Technion Research & Development Foundation Limited |
Methods of determining prognosis of sepsis and treating same
|
WO2017125931A1
(en)
|
2016-01-21 |
2017-07-27 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Parthenocarpic plants and methods of producing same
|
IL243839B
(en)
|
2016-01-28 |
2018-01-31 |
Sp Nano Ltd |
Conductive wires
|
IL243838A
(en)
|
2016-01-28 |
2017-07-31 |
Sp Nano Ltd |
The composition containing sp1 protein and carbon nanoparticles and its uses
|
WO2017130205A1
(en)
|
2016-01-31 |
2017-08-03 |
Hadasit Medical Research Services And Development Ltd. |
Autosomal-identical pluripotent stem cell populations having non-identical sex chromosomal composition and uses thereof
|
WO2017134671A1
(en)
|
2016-02-04 |
2017-08-10 |
Yeda Research And Development Co. Ltd. |
Peptides and use of same in the treatment of diseases, disorders or conditions associated with a mutant p53
|
WO2017138008A2
(en)
|
2016-02-14 |
2017-08-17 |
Yeda Research And Development Co. Ltd. |
Methods of modulating protein exocytosis and uses of same in therapy
|
US20190142875A1
(en)
|
2016-02-14 |
2019-05-16 |
Yeda Research And Development Co. Ltd. |
Microbiome-based diagnosis, prediction and treatment of relapsing obesity
|
JP2019508422A
(ja)
|
2016-02-16 |
2019-03-28 |
イッスム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム・リミテッドYissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
シアノバクテリアおよび植物の増殖を阻害するための非タンパク質性フェニルアラニン類似体
|
WO2017145162A1
(en)
|
2016-02-23 |
2017-08-31 |
Chaya Brodie |
Generation of cancer stem cells and use thereof
|
WO2017149538A1
(en)
|
2016-03-01 |
2017-09-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Antibodies specific to human poliovirus receptor (pvr)
|
CN108699609A
(zh)
|
2016-03-03 |
2018-10-23 |
米密德诊断学有限公司 |
分析rna用于诊断感染类型
|
WO2017153982A1
(en)
|
2016-03-06 |
2017-09-14 |
Yeda Research And Development Co. Ltd. |
Method for modulating myelination
|
IL244649A0
(en)
|
2016-03-17 |
2016-06-30 |
Yeda Res & Dev |
Methods for the isolation of barrel-like proteases and the identification of peptides that are cleaved by Alidan
|
US10421785B2
(en)
|
2016-04-11 |
2019-09-24 |
Bar-Ilan University |
Delta receptor agonist peptides and use thereof
|
DE202017007129U1
(de)
|
2016-04-27 |
2019-08-29 |
Gen-Probe Incorporated |
Lysereagenz für Blutzellen
|
WO2017203520A1
(en)
|
2016-05-22 |
2017-11-30 |
Yeda Research And Development Co. Ltd. |
Methods of using pulmonary cells for transplantation and induction of tolerance
|
IL245861A0
(en)
|
2016-05-25 |
2016-09-04 |
Yeda Res & Dev |
Use of substances to treat drug-resistant tumors
|
WO2017208247A1
(en)
|
2016-06-02 |
2017-12-07 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Assay for the removal of methyl-cytosine residues from dna
|
EP3464322B1
(de)
|
2016-06-05 |
2023-04-05 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Neuartige moleküle zur behandlung von entzündungen
|
US20190160152A1
(en)
|
2016-06-09 |
2019-05-30 |
Opko Biologics Ltd. |
Long-acting oxyntomodulin formulation and methods of producing and administering same
|
US11859232B2
(en)
|
2016-06-19 |
2024-01-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Screening for chemotherapy resistance in human haploid cells
|
WO2018002924A1
(en)
|
2016-06-27 |
2018-01-04 |
Yeda Research And Development Co. Ltd. |
Veto cells generated from memory t cells
|
EP4141448A1
(de)
|
2016-07-10 |
2023-03-01 |
MeMed Diagnostics Ltd. |
Proteinsignaturen zur unterscheidung zwischen bakteriellen und viralen infektionen
|
WO2018011796A1
(en)
|
2016-07-10 |
2018-01-18 |
Memed Diagnostics Ltd. |
Early diagnosis of infections
|
JP7268943B2
(ja)
|
2016-07-11 |
2023-05-08 |
ボーナス セラピューティックス リミテッド |
組織再生のための細胞組成物
|
BR112019000610A2
(pt)
|
2016-07-11 |
2019-07-02 |
Opko Biologics Ltd |
fator vii de coagulação de longa ação e métodos de produção do mesmo
|
IL246722A0
(en)
|
2016-07-11 |
2016-09-29 |
Yeda Res & Dev |
Combined treatment to increase endogenous synthesis of nitric oxide
|
IL302693A
(en)
|
2016-07-11 |
2023-07-01 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Methods and systems for growing cells in culture
|
US11708421B2
(en)
|
2016-07-18 |
2023-07-25 |
Ramot At Tel-Aviv University Ltd. |
Modular platform for targeted therapeutics
|
WO2018020489A1
(en)
|
2016-07-24 |
2018-02-01 |
Yeda Research And Development Co. Ltd. |
Methods and kits for analyzing dna binding moieties attached to dna
|
WO2018029682A1
(en)
|
2016-08-08 |
2018-02-15 |
Ramot At Tel-Aviv University Ltd. |
Bacterial systems for analyzing ubiquitylated polypeptides
|
WO2018029690A1
(en)
|
2016-08-10 |
2018-02-15 |
Memed Diagnostics Ltd. |
System and method for analysis of biological data
|
EP3497239A4
(de)
|
2016-08-10 |
2020-02-26 |
Ramot at Tel-Aviv University Ltd. |
Analyse des methylierungsstatus und kopienzahl
|
CN109843305B
(zh)
|
2016-08-14 |
2023-03-10 |
雷蒙特亚特特拉维夫大学有限公司 |
治疗神经障碍的间充质细胞来源的外泌体
|
IL247368A0
(en)
|
2016-08-18 |
2016-11-30 |
Yeda Res & Dev |
Diagnostic and therapeutic uses of exosomes
|
WO2018037416A1
(en)
|
2016-08-25 |
2018-03-01 |
Yeda Research And Development Co. Ltd. |
Methods and compositions for treating autoimmune diseases
|
WO2018047154A1
(en)
|
2016-09-07 |
2018-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Anti-nkp46 antibodies and therapeutic use of same
|
EP3512943B1
(de)
|
2016-09-14 |
2023-04-12 |
Yeda Research and Development Co. Ltd. |
Crisp-seq, integriertes verfahren für massiv parallele einzelzellen-rna-seq und crispr-gepoolte screens
|
US11385241B2
(en)
|
2016-09-29 |
2022-07-12 |
Memed Diagnostics Ltd. |
Methods of prognosis and treatment
|
IL248468A0
(en)
|
2016-10-13 |
2017-01-31 |
Technion Res & Dev Foundation |
Use of caspase-3 inhibitors and caspase-3 activators in the preparation of medical preparations for cancer treatment and wound healing
|
IL248385A0
(en)
|
2016-10-18 |
2017-02-01 |
Yeda Res & Dev |
Treatment of circadian rhythm disorder
|
EP3538651A1
(de)
|
2016-11-10 |
2019-09-18 |
Yeda Research and Development Co., Ltd. |
Phosphotriesterasen zur behandlung oder prävention von schäden im zusammenhang mit organophosphatbelastung
|
EP3545095A1
(de)
|
2016-11-28 |
2019-10-02 |
Yeda Research and Development Co., Ltd. |
Isolierte polynukleotide und polypeptide sowie verfahren zur verwendung davon zur expression eines produkts von interesse
|
EP3548015A1
(de)
|
2016-11-30 |
2019-10-09 |
Yeda Research and Development Co. Ltd. |
Verfahren zur behandlung von lebertoxizität und -störungen
|
BR112019003912A2
(pt)
|
2016-12-01 |
2019-05-28 |
Univ Ramot |
composição, método para criação de um hidrogel, matriz, hidrogel, método para indução da formação ou regeneração de um tecido neuronal, método para tratamento de uma lesão do nervo e método para prevenção ou tratamento de choque neurogênico após lesão do nervo
|
IL268126B2
(en)
|
2017-01-18 |
2024-02-01 |
Yeda Res & Dev |
Genetically engineered Veto cells and their uses in immunotherapy
|
IL250479A0
(en)
|
2017-02-06 |
2017-03-30 |
Sorek Rotem |
Genetically engineered cells expressing a disarm system that confers resistance to phages and methods for their production
|
IL250916A0
(en)
|
2017-03-02 |
2017-06-29 |
Geiger Benjamin |
Methods for growing t cells in culture and their use
|
US20200150125A1
(en)
|
2017-03-12 |
2020-05-14 |
Yeda Research And Development Co., Ltd. |
Methods of diagnosing and prognosing cancer
|
WO2018167780A1
(en)
|
2017-03-12 |
2018-09-20 |
Yeda Research And Development Co. Ltd. |
Methods of prognosing and treating cancer
|
EP3595687A1
(de)
|
2017-03-16 |
2020-01-22 |
Lineage Cell Therapeutics, Inc. |
Verfahren zur messung der therapeutischen wirkung von therapien bei retinalen krankheiten
|
BR112019020953A2
(pt)
|
2017-04-05 |
2020-05-05 |
Yeda Res & Dev |
sistema de cultura ex-vivo e métodos de uso do mesmo
|
IL252151A0
(en)
|
2017-05-07 |
2017-07-31 |
Fainzilber Michael |
Treatment of stress disorders
|
KR20200004880A
(ko)
|
2017-05-10 |
2020-01-14 |
아리엘 싸이언티픽 이노베이션스 엘티디. |
항체를 정제하는 방법
|
US11714089B2
(en)
|
2017-05-21 |
2023-08-01 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Combination of markers for diagnosing cancer
|
EP3634991A1
(de)
|
2017-05-23 |
2020-04-15 |
Technion Research & Development Foundation Limited |
Mittel zur hemmung von gads-dimerisierung und verfahren zur verwendung davon
|
GB201708662D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing shelf-life of banana
|
GB201708665D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing extractability of solids from coffee beans
|
US20200109408A1
(en)
|
2017-05-31 |
2020-04-09 |
Tropic Biosciences UK Limited |
Methods of selecting cells comprising genome editing events
|
WO2018229764A1
(en)
|
2017-06-13 |
2018-12-20 |
Yeda Research And Development Co. Ltd. |
Treatment of advanced or progressive multiple sclerosis
|
WO2019012544A1
(en)
|
2017-07-13 |
2019-01-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
STRATEGY FOR DOUBLE PROBE DROPLETS FOR SPECIFIC DETECTION OF CIRCULATING DNA MOLECULES SPECIFIC TO A TISSUE
|
WO2019012542A1
(en)
|
2017-07-13 |
2019-01-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
DETECTION OF SPECIFIC DNA FROM A FABRIC
|
EP3652344A1
(de)
|
2017-07-13 |
2020-05-20 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Dna-targets als gewebespezifische methylierungsmarker
|
IL253642A0
(en)
|
2017-07-24 |
2017-09-28 |
Seger Rony |
Combined treatment for cancer
|
IL253984A0
(en)
|
2017-08-14 |
2017-09-28 |
Yeda Res & Dev |
Immunotherapy against aranviruses that bind through transferrin receptor 1 (tfr1
|
US11692166B2
(en)
|
2017-08-23 |
2023-07-04 |
Technion Research & Development Foundation Limited |
Compositions and methods for improving alcohol tolerance in yeast
|
SG11202002479XA
(en)
|
2017-09-19 |
2020-04-29 |
Tropic Biosciences Uk Ltd |
Modifying the specificity of plant non-coding rna molecules for silencing gene expression
|
CN111587123A
(zh)
|
2017-11-09 |
2020-08-25 |
品通治疗有限公司 |
用于生成和使用人源化构象特异性磷酸化的τ抗体的方法和组合物
|
IL255664A0
(en)
|
2017-11-14 |
2017-12-31 |
Shachar Idit |
Hematopoietic stem cells with enhanced properties
|
IL274978B1
(en)
|
2017-11-29 |
2024-06-01 |
Weedout Ltd |
Preparations, kits and methods for the control of weeds from the genus Amaranthus
|
WO2019106671A1
(en)
|
2017-11-29 |
2019-06-06 |
Ramot At Tel-Aviv University Ltd. |
Methods of preventing or treating neurogenic shock
|
EP3716993A1
(de)
|
2017-12-03 |
2020-10-07 |
Yeda Research and Development Co. Ltd |
Behandlung einer ischämischen herzerkrankung
|
EP3723785A1
(de)
|
2017-12-17 |
2020-10-21 |
Yeda Research and Development Co. Ltd |
Komplexe modulatoren des cop9-signalosoms (csn) und deren verwendung
|
EP3731965A1
(de)
|
2017-12-28 |
2020-11-04 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Verfahren zur wiedergabe von biorhythmen auf einem mikrofluidischen chip
|
IL257225A
(en)
|
2018-01-29 |
2018-04-09 |
Yeda Res & Dev |
Treatment of sarcoma
|
IL257269A
(en)
|
2018-01-31 |
2018-04-09 |
Olender Tsviya |
Signaling is directed to the endoplasmic reticulum
|
WO2019155465A1
(en)
|
2018-02-08 |
2019-08-15 |
Yeda Research And Development Co. Ltd. |
Methods of identifying and using agents for treating diseases associated with intestinal barrier dysfunction
|
WO2019155459A1
(en)
|
2018-02-08 |
2019-08-15 |
Yeda Research And Development Co. Ltd. |
Inhibitors of the 20s proteasome
|
US11571433B2
(en)
|
2018-02-23 |
2023-02-07 |
Carmel Haifa University Economic Corporation Ltd. |
Methods for treating memory impairment and cognitive dysfunction
|
WO2019167047A1
(en)
|
2018-02-28 |
2019-09-06 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Methods of diagnosing and treating bladder cancer
|
EP3765034A1
(de)
|
2018-03-12 |
2021-01-20 |
Yeda Research and Development Co. Ltd |
Behandlung einer herzkrankheit
|
EP3774047A1
(de)
|
2018-03-29 |
2021-02-17 |
Yeda Research and Development Co. Ltd |
Verwendung von elektrischen feldgradienten zur kontrolle der genexpression
|
CN112236131A
(zh)
|
2018-03-29 |
2021-01-15 |
技术研究及发展基金有限公司 |
包含pten抑制剂的囊泡及其用途
|
IL258467A
(en)
|
2018-03-29 |
2018-07-04 |
Ilana Kolodkin Gal |
Methods of disrupting a biofilm and/or preventing formation of same
|
GB201807192D0
(en)
|
2018-05-01 |
2018-06-13 |
Tropic Biosciences Uk Ltd |
Compositions and methods for reducing caffeine content in coffee beans
|
WO2019220441A1
(en)
|
2018-05-15 |
2019-11-21 |
Hadasit Medical Research Services And Development Ltd. |
Compositions and methods for treating cancer resistant to an anti-cancer agent
|
IL259392A
(en)
|
2018-05-15 |
2018-08-01 |
Yeda Res & Dev |
Vaccination with cancer neo-antigens
|
WO2019229745A1
(en)
|
2018-05-27 |
2019-12-05 |
Biolinerx Ltd. |
Agi-134 combined with a checkpoint inhibitor for the treatment of solid tumors
|
EP3800998A1
(de)
|
2018-06-07 |
2021-04-14 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Verfahren zur regenerierung und transformation von cannabis
|
EP3802839A1
(de)
|
2018-06-07 |
2021-04-14 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Nukleinsäurekonstrukte und verfahren zu deren verwendung
|
WO2020003311A1
(en)
|
2018-06-25 |
2020-01-02 |
Yeda Research And Development Co. Ltd. |
Systems and methods for increasing efficiency of genome editing
|
WO2020008412A1
(en)
|
2018-07-04 |
2020-01-09 |
Ukko Inc. |
Methods of de-epitoping wheat proteins and use of same for the treatment of celiac disease
|
US20210269860A1
(en)
|
2018-07-08 |
2021-09-02 |
Yeda Research And Development Co. Ltd. |
Person-specific assessment of probiotics responsiveness
|
WO2020012478A2
(en)
|
2018-07-11 |
2020-01-16 |
Immunity Pharma Ltd. |
Peptide compounds and therapeutic uses of same
|
SG11202013167UA
(en)
|
2018-07-11 |
2021-01-28 |
Kahr Medical Ltd |
SIRPalpha-4-1BBL VARIANT FUSION PROTEIN AND METHODS OF USE THEREOF
|
KR20210042430A
(ko)
|
2018-07-31 |
2021-04-19 |
콜플랜트 리미티드 |
담배 형질전환 이벤트 및 이의 검출 방법 및 용도
|
IL261156A
(en)
|
2018-08-14 |
2020-02-27 |
Fass Deborah |
Chimeric quiescin sulfhydryl oxidase (qsox1) antibodies and uses of same
|
CA3108434A1
(en)
|
2018-08-24 |
2020-02-27 |
Yeda Research And Development Co. Ltd. |
Methods of modulating m2 macrophage polarization and use of same in therapy
|
CN113038951B
(zh)
|
2018-09-20 |
2024-04-30 |
耶达研究及发展有限公司 |
治疗肌萎缩侧索硬化的方法
|
US20210338767A1
(en)
|
2018-09-25 |
2021-11-04 |
Biolinerx Ltd. |
Methods of selecting treatment for cxcr4-associated cancer
|
IL262658A
(en)
|
2018-10-28 |
2020-04-30 |
Memorial Sloan Kettering Cancer Center |
Prevention of age related clonal hematopoiesis and diseases associated therewith
|
IL263184A
(en)
|
2018-11-21 |
2020-05-31 |
Yarden Yosef |
Method of treating cancer and compositions for same
|
WO2020152686A1
(en)
|
2019-01-23 |
2020-07-30 |
Yeda Research And Development Co. Ltd. |
Culture media for pluripotent stem cells
|
IL264768A
(en)
|
2019-02-10 |
2020-08-31 |
Sagi Irit |
ANTI-MATRIX METALLOPROTEINASE 7 (MMP-7) inhibitory antibody and its use
|
IL264854A
(en)
|
2019-02-14 |
2020-08-31 |
Bahat Anat |
Spt5 inhibitors and methods of use thereof
|
JP2022521010A
(ja)
|
2019-02-21 |
2022-04-04 |
イッスム・リサーチ・デベロプメント・カムパニー・オブ・ザ・ヘブリュー・ユニバシティー・オブ・エルサレム リミテッド |
薬物誘導性腎毒性を減少させるための方法
|
WO2020170239A1
(en)
|
2019-02-21 |
2020-08-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of generating organoids for high throughput screening of drugs
|
CA3128360A1
(en)
|
2019-03-05 |
2020-09-10 |
Yuval CINNAMON |
Genome-edited birds
|
GB201903521D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
No title
|
GB201903520D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
|
GB201903519D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
|
IL265486A
(en)
|
2019-03-19 |
2020-09-30 |
Yeda Res & Dev |
Bistable type ii opsins and uses thereof
|
WO2020194317A1
(en)
|
2019-03-28 |
2020-10-01 |
Yeda Research And Development Co. Ltd. |
Method of treating lipid-related disorders
|
US20220175807A1
(en)
|
2019-03-31 |
2022-06-09 |
Yeda Research And Development Co. Ltd. |
Anti-viral and anti-tumoral compounds
|
IL266433B
(en)
|
2019-05-02 |
2020-11-30 |
Sagi Irit |
Compositions comprising the propeptide of lysyl oxidase and uses thereof
|
EP3969619A1
(de)
|
2019-05-13 |
2022-03-23 |
Yeda Research and Development Co. Ltd |
Zellfreie mirna-biomarker zur prognose und diagnose neurodegenerativer erkrankungen
|
IL266728B
(en)
|
2019-05-19 |
2020-11-30 |
Yeda Res & Dev |
Identification of recurrent mutant neopeptides
|
WO2020234888A1
(en)
|
2019-05-22 |
2020-11-26 |
Hadasit Medical Research Services And Development Ltd. |
Methods of culturing human pluripotent cells
|
US20220251179A1
(en)
|
2019-05-28 |
2022-08-11 |
Shanghaitech University |
Composition and methods to treat ectodermal dysplasia 2, clouston type
|
WO2020250232A1
(en)
|
2019-06-12 |
2020-12-17 |
Hadasit Medical Research Services And Development Ltd. |
Methods of generating oligodendrocytes
|
EP3983540A1
(de)
|
2019-06-16 |
2022-04-20 |
Yeda Research and Development Co. Ltd |
Verfahren zur stabilisierung intrazellulärer rna
|
EP3990488A4
(de)
|
2019-06-27 |
2023-09-13 |
Ramot at Tel-Aviv University Ltd. |
Semaphorin-3a-antikörper und verwendungen davon
|
CN114938647A
(zh)
|
2019-07-04 |
2022-08-23 |
乌科公司 |
去表位的α-麦醇溶蛋白及其在乳糜泻和麸质敏感性管理中的用途
|
US20220267409A1
(en)
|
2019-07-11 |
2022-08-25 |
Kahr Medical Ltd. |
Heterodimers and methods of use thereof
|
EP3999851A4
(de)
|
2019-07-16 |
2023-04-12 |
Ramot at Tel-Aviv University Ltd. |
Zusammensetzungen und verfahren zur behandlung von tuberkulose
|
IL268111A
(en)
|
2019-07-16 |
2021-01-31 |
Fainzilber Michael |
Methods of treating pain
|
CA3147575A1
(en)
|
2019-07-29 |
2021-02-04 |
Yeda Research And Development Co. Ltd. |
Methods of treating and diagnosing lung cancer
|
EP4004212A1
(de)
|
2019-07-30 |
2022-06-01 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Institute) |
Verfahren zur steuerung der cannabinoid-synthese in pflanzen oder zellen und nach diesem verfahren hergestellte pflanzen und zellen
|
EP4014046A1
(de)
|
2019-08-12 |
2022-06-22 |
Yeda Research and Development Co. Ltd |
Dna-reparaturbluttest zur vorhersage des ansprechens von lungenkrebspatienten auf eine immuntherapie
|
US20240140988A1
(en)
|
2019-08-22 |
2024-05-02 |
Ariel Scientific Innovations Ltd. |
Scaled-up methods for purifying antibodies
|
EP4021463A1
(de)
|
2019-08-27 |
2022-07-06 |
Yeda Research and Development Co. Ltd |
Behandlung von bakterieller vaginose
|
WO2021048852A1
(en)
|
2019-09-11 |
2021-03-18 |
Yeda Research And Development Co. Ltd. |
Methods of treating breast cancer
|
IL269674B
(en)
|
2019-09-25 |
2020-08-31 |
Roy Bar Ziv |
Assembling protein complexes on a chip
|
IL270306A
(en)
|
2019-10-30 |
2021-05-31 |
Yeda Res & Dev |
Prevention and treatment of pre-myeloid and myeloid malignancies
|
WO2021084526A1
(en)
|
2019-10-31 |
2021-05-06 |
Yeda Research And Development Co. Ltd. |
Engineered autotrophic bacteria for co2 conversion to organic materials
|
BR112022009087A2
(pt)
|
2019-11-11 |
2022-07-26 |
Ibi Ag Innovative Bio Insecticides Ltd |
Nanocorpos para controle de insetos e usos dos mesmos
|
JP2023510464A
(ja)
|
2019-11-19 |
2023-03-14 |
プロタリクス リミテッド |
形質転換細胞からの構築物の除去
|
IL270800A
(en)
|
2019-11-20 |
2021-05-31 |
Yeda Res & Dev |
A method for treating Alzheimer's disease
|
EP4077731A1
(de)
|
2019-12-22 |
2022-10-26 |
Yeda Research and Development Co. Ltd |
Diagnose einer frontotemporalen demenz
|
IL271656A
(en)
|
2019-12-22 |
2021-06-30 |
Yeda Res & Dev |
System and methods for identifying cells that have undergone genome editing
|
WO2021137231A1
(en)
|
2019-12-31 |
2021-07-08 |
Kahr Medical Ltd. |
Methods of culturing t cells with a 4-1bbl fusion polypeptide and uses of same
|
IL271778A
(en)
|
2019-12-31 |
2021-06-30 |
Ichilov Tech Ltd |
Methods for treating atopic dermatitis
|
WO2021137230A1
(en)
|
2019-12-31 |
2021-07-08 |
Kahr Medical Ltd. |
Methods of culturing t cells and uses of same
|
IL272074A
(en)
|
2020-01-15 |
2021-07-29 |
Immunity Pharma Ltd |
Peptide compounds and their use in methods of treating diseases
|
IL272194A
(en)
|
2020-01-22 |
2021-07-29 |
Yeda Res & Dev |
Multi-target antibodies for use in the treatment of diseases
|
WO2021152584A1
(en)
|
2020-01-28 |
2021-08-05 |
Ariel Scientific Innovations Ltd. |
Methods of analyzing cell membranes
|
IL272389A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Kits containing antibodies to PD-L1 and their uses in therapy
|
IL272390A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Cancer treatment methods
|
WO2021152586A1
(en)
|
2020-01-30 |
2021-08-05 |
Yeda Research And Development Co. Ltd. |
Methods of analyzing microbiome, immunoglobulin profile and physiological state
|
EP4096647A1
(de)
|
2020-01-30 |
2022-12-07 |
Yeda Research and Development Co. Ltd |
Behandlung einer akuten lebererkrankung mit tlr-mik-inhibitoren
|
JP2023513334A
(ja)
|
2020-02-09 |
2023-03-30 |
エヌエルシー ファーマ リミテッド |
Sars-cov-2の迅速検出検査
|
IL272586A
(en)
|
2020-02-10 |
2021-08-31 |
Yeda Res & Dev |
A method for cell cluster analysis
|
WO2021173674A1
(en)
|
2020-02-26 |
2021-09-02 |
A2 Biotherapeutics, Inc. |
Polypeptides targeting mage-a3 peptide-mhc complexes and methods of use thereof
|
US20230127559A1
(en)
|
2020-03-16 |
2023-04-27 |
Yeda Research And Development Co. Ltd. |
Peptide analogs and use of same in treating diseases, disorders or conditions associated with mutant p53 protein
|
JP2023519934A
(ja)
|
2020-03-29 |
2023-05-15 |
イエダ・リサーチ・アンド・デベロツプメント・カンパニー・リミテツド |
ゴーシェ病の処置において使用するためのベータ-グルコセレブロシダーゼのバリアント
|
AU2021248783A1
(en)
|
2020-03-31 |
2022-12-01 |
Biomuse Ltd. |
Bacteria for the prevention and treatment of smoke-induced lung damage
|
WO2021205444A1
(en)
|
2020-04-06 |
2021-10-14 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing cancer and predicting responsiveness to therapy
|
EP4132479A1
(de)
|
2020-04-07 |
2023-02-15 |
Ramot at Tel-Aviv University Ltd. |
Cannabidiolhaltige zusammensetzungen und verwendungen davon
|
EP4135746A1
(de)
|
2020-04-13 |
2023-02-22 |
Exoprother Medical Ltd. |
Vesikel aus zellen mit wildtyp-p53-protein zur antiviralen therapie
|
US20210322483A1
(en)
|
2020-04-16 |
2021-10-21 |
Ichilov Tech Ltd. |
Cell-derived particles presenting heterologous cd24 and use thereof in therapy
|
WO2021229577A1
(en)
|
2020-05-12 |
2021-11-18 |
Collplant Ltd. |
Collagen as a delivery tool for metal-based anti-viral agents
|
IL274811B
(en)
|
2020-05-20 |
2021-05-31 |
Yeda Res & Dev |
Spatial information is developed for the analysis of individual cells
|
US20230293530A1
(en)
|
2020-06-24 |
2023-09-21 |
Yeda Research And Development Co. Ltd. |
Agents for sensitizing solid tumors to treatment
|
IL276599A
(en)
|
2020-08-09 |
2022-03-01 |
Yeda Res & Dev |
T cell receptor unique to mage-a1 and its uses
|
IL276627A
(en)
|
2020-08-10 |
2022-03-01 |
Yeda Res & Dev |
Compositions for diagnosis and treatment of coronavirus infections
|
EP4199703A1
(de)
|
2020-08-18 |
2023-06-28 |
International Rice Research Institute |
Verfahren zur erhöhung der auskreuzungsraten in graminae
|
IL277488A
(en)
|
2020-09-21 |
2022-04-01 |
Yeda Res & Dev |
Weight regulation method
|
IL301503A
(en)
|
2020-09-23 |
2023-05-01 |
Yeda res & development co ltd |
Methods and preparations for the treatment of the disease caused by the corona virus
|
IL277743A
(en)
|
2020-10-01 |
2022-04-01 |
Yeda Res & Dev |
A method for diagnosing breast cancer
|
JP2023545999A
(ja)
|
2020-10-05 |
2023-11-01 |
プロタリクス リミテッド |
ダイサー(dicer)様ノックアウト植物細胞
|
IL301970A
(en)
|
2020-10-07 |
2023-06-01 |
Protalix Ltd |
A long-acting DNase
|
EP4228637A1
(de)
|
2020-10-15 |
2023-08-23 |
Yeda Research and Development Co. Ltd |
Verfahren zur behandlung von myeloidmalignitäten
|
IL278401A
(en)
|
2020-10-29 |
2022-05-01 |
Yeda Res & Dev |
Polynucleotides for editing RNA and a method for using them
|
US20230416750A1
(en)
|
2020-11-09 |
2023-12-28 |
1E Therapeutics Ltd. |
Catalytic sequence based methods of treating or preventing bacterial infections
|
AU2021387979A1
(en)
|
2020-11-26 |
2023-03-30 |
Ukko Inc. |
Modified high molecular weight glutenin subunit and uses thereof
|
IL279559A
(en)
|
2020-12-17 |
2022-07-01 |
Yeda Res & Dev |
Controlling the ubiquitination process of mlkl for disease treatment
|
EP4267742A2
(de)
|
2020-12-28 |
2023-11-01 |
1E Therapeutics, Ltd. |
Auf p21-mrna abzielende dnazyme
|
WO2022144882A2
(en)
|
2020-12-28 |
2022-07-07 |
1E Therapeutics, Ltd. |
P21 mrna target areas for silencing
|
JP2024502377A
(ja)
|
2021-01-10 |
2024-01-18 |
スーパーミート ザ エッセンス オブ ミート リミテッド |
培養肉産業用の多能性幹細胞凝集体及びそれから得られる微小組織
|
WO2022153286A1
(en)
|
2021-01-14 |
2022-07-21 |
Yeda Research And Development Co. Ltd. |
Methods of producing vitamin d
|
IL280340B
(en)
|
2021-01-21 |
2022-04-01 |
Yeda Res & Dev |
Antibodies, peptides and their combinations for the treatment and prevention of corona virus infections
|
CA3208982A1
(en)
|
2021-02-18 |
2022-08-25 |
Ravid STRAUSSMAN |
Method of generating vaccines
|
IL305314A
(en)
|
2021-02-18 |
2023-10-01 |
Yeda res & development co ltd |
A genetically engineered bacterium for vaccine production
|
IL281561A
(en)
|
2021-03-16 |
2022-10-01 |
Yeda Res & Dev |
Methods and devices for growing mouse embryos outside the uterus
|
WO2022208369A1
(en)
|
2021-03-30 |
2022-10-06 |
Biomx Ltd. |
Pseudomonas bacteriophage and uses thereof
|
IL282188A
(en)
|
2021-04-08 |
2022-11-01 |
Yeda Res & Dev |
Combined use of ketamine and bretigabine for the treatment of psychiatric disorders
|
EP4337764A1
(de)
|
2021-05-12 |
2024-03-20 |
Biomx Ltd. |
Staphylococcus-bakteriophage und verwendungen davon
|
IL283563A
(en)
|
2021-05-30 |
2022-12-01 |
Yeda Res & Dev |
Profiling of amps for the diagnosis, monitoring and treatment of microbiome-related diseases
|
CA3219233A1
(en)
|
2021-06-06 |
2022-12-15 |
Ravid STRAUSSMAN |
Combined treatment for cancer
|
EP4355857A1
(de)
|
2021-06-13 |
2024-04-24 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Verfahren zur umprogrammierung menschlicher zellen
|
NL2028466B1
(en)
|
2021-06-16 |
2022-12-21 |
Sakata Holland B V |
Methods of sorting matthiola seeds
|
CR20240020A
(es)
|
2021-06-16 |
2024-02-28 |
Seedx Tech Inc |
Métodos de clasificación de semillas de matthiola
|
AU2022303086A1
(en)
|
2021-07-02 |
2024-01-18 |
Tropic Biosciences UK Limited |
Delay or prevention of browning in banana fruit
|
AU2022313138A1
(en)
|
2021-07-18 |
2024-02-29 |
Gamida-Cell Ltd. |
Therapeutic nk cell populations
|
WO2023002492A1
(en)
|
2021-07-22 |
2023-01-26 |
Yeda Research And Development Co. Ltd. |
Codon optimization of nucleic acids
|
CA3226947A1
(en)
|
2021-08-03 |
2023-02-09 |
Muhammad YASSIN |
Engineered tcr complex and methods of using same
|
EP4130028A1
(de)
|
2021-08-03 |
2023-02-08 |
Rhazes Therapeutics Ltd |
Manipulierter tcr-komplex und verfahren zur verwendung davon
|
EP4384603A1
(de)
|
2021-08-10 |
2024-06-19 |
Gamida-Cell Ltd. |
Manipulierte nk-zellen, verfahren zu deren herstellung und verwendungen davon
|
GB202112866D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to fusarium wilt in a banana
|
GB202112865D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to black sigatoka disease in banana
|
IL286430A
(en)
|
2021-09-14 |
2023-04-01 |
Yeda Res & Dev |
Multispecific antibodies for use in the treatment of diseases
|
CA3240113A1
(en)
|
2021-12-08 |
2023-06-15 |
Yeda Research And Development Co. Ltd. |
Multipotent lung progenitor cells for lung regeneration
|
WO2023209708A1
(en)
|
2022-04-25 |
2023-11-02 |
Yeda Research And Development Co. Ltd. |
Compositions for altering cyclic adp-ribose secondary messenger signalling
|